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Abstract
The present study examined the role of group I metabotropic glutamate receptors
(mGluRs) in mammalian spinal motor networks and investigated the potential role of
mGluRs in the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS).
Group I mGluR activation was found to modulate locomotor-related activity recorded
from ventral roots of in vitro mouse spinal cord preparations. Activation of group I
mGluRs led to an increase in the frequency of locomotor-related bursts and a decrease
in their amplitude. The cellular mechanisms underlying group I mGluR-mediated
modulation were investigated using whole-cell patch-clamp recordings from spinal
neurons. Recordings from motoneurons revealed a wide range of effects, some of
which were expected to increase motoneuron excitability, such as membrane
depolarisation and hyperpolarisation of action potential thresholds. However, the net
modulatory effect of group I mGluR activation was a reduction in motoneuron
excitability, likely reflecting a reduction in the density of fast inactivating Na+ currents.
The activation of group I mGluRs also reduced excitatory synaptic input to
motoneurons, suggesting that modulation of motoneuron properties and synaptic
transmission both contribute to group I mGluR-mediated reductions in locomotor
motoneuron output. Recordings from spinal interneurons revealed a smaller range of
modulatory effects for group I mGluRs. The clearest effect on interneurons,
membrane depolarisation, may underlie group I mGluR-mediated increases in the
frequency of locomotor activity. Finally, the potential role of group I mGluRs in the
pathogenesis of ALS was investigated using a mouse model of the disease. Although
no major perturbations in group I mGluR-mediated modulation were demonstrated in
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ALS affected spinal cords, there appeared to be a difference in the intrinsic excitability
of spinal interneurons between wild type and ALS affected animals. Together these
data highlight group I mGluRs as important sources of neuromodulation within the
spinal cord and potential targets for the treatment of ALS.
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Chapter 1
Introduction
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Overview of the project
Neuromodulation is a key mechanism that allows the nervous system to produce
behaviours with considerable flexibility. The present study investigates the role of
G-protein coupled metabotropic glutamate receptors (mGluRs) in the modulation of
spinal motor networks that control the fundamental behaviour, locomotion. In
particular, the study focuses on whether the activation of one class of mGluRs, group I
mGluRs, modulates locomotor-related neural networks of the mammalian spinal cord.
This is assessed by using electrophysiological recordings of locomotor activity
generated by motor networks present in intact in vitro spinal cord preparations and
activity produced by single neurons within locomotor networks. In addition, it is
investigated whether the modulatory roles of group I mGluRs differ in spinal cords
affected by the neurodegenerative disease amyotrophic lateral sclerosis (ALS) in which
motoneurons selectively degenerate due to unknown causes. The present study
demonstrates a wide range of modulatory effects of group I mGluRs in mouse spinal
locomotor networks, which helps to further our understanding of glutamatergic
modulation in the neural control of mammalian locomotion.
Neural control of locomotion
Locomotor behaviours, such as swimming and walking, require the coordination of
rhythmic body movements, typically involving muscular activity which alternates on
the left and right sides of the body, to propel animals forwards. Although locomotion
is a fundamental behaviour for all animals, there is still much to be learnt about how the
nervous system controls rhythmic locomotor behaviour. Early studies of the neural
control of locomotion demonstrated in cats that hind limb muscles still contracted
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rhythmically and repetitively when animals were spinalised and dorsal roots severed to
remove the influence of sensory input and descending input originating from
supra-spinal systems (Brown, 1911). This work led to the idea that there are
populations of local neurons intrinsic to the spinal cord that form motor networks
capable of producing rhythmic locomotor-related activity. Populations of local
interneurons that generate the locomotor rhythm are collectively referred to as central
pattern generators (CPGs) for locomotion (Grillner, 2006; Goulding, 2009; Kiehn et al.,
2010). Rhythmic locomotor signals set by spinal CPG networks then converge onto
motoneurons which act as the final common pathway for all motor command exiting the
CNS (Sherrington, 1947).
It has been difficult to reveal rhythm generating interneuron populations in the
mammalian spinal locomotor CPG. At present, interneurons that play important roles
in the generation of rhythmic locomotor activity are best described in the spinal
networks of evolutionarily simpler vertebrates such as lampreys and Xenopus tadpoles
(Roberts, 2000; Roberts et al., 2008b; Soffe et al., 2009). This seems to be partly
because the locomotor behaviour of these water-living animals, swimming, perhaps
requires smaller sets of interneuron populations than those required for the neural
control of walking. Nonetheless, a complete understanding of the architecture of
swimming networks is important towards understanding of neural networks controlling
walking in limbed animals, since the two types of locomotor networks are highly likely
to share some commonality. Excitation in swimming networks is primarily provided
by populations of ipsilaterally projecting descending interneurons in both the left and
right halves of the spinal cord (Li et al., 2009; Soffe et al., 2009). Each half of the
excitatory networks are mutually connected by populations of commisurally projecting
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inhibitory interneurons, which ensures network excitation alternates between two halves
of the spinal cord (Roberts et al., 2008a). There are also populations of ipsilaterally
projecting ascending interneurons which provide recurrent inhibition to excitatory
networks of their own sides, regulating network excitation in one half of the spinal cord
(Roberts et al., 2008a).
In contrast, locomotor networks in the mammalian spinal cord appear to consist of
much more complex and heterogeneous populations of local interneurons, as the
locomotor behaviour of walking requires not only left-right alternation of limbs but also
finer coordination of a number of agonist and antagonist muscles within one limb.
Despite this complexity, some of the interneuron populations within mammalian spinal
locomotor networks have been uncovered recently, thanks to combined advances in
molecular genetics and developmental biology (Jessell, 2000). Neurons found in the
ventral horn of the spinal cord are developmentally grouped based on expression of
different transcription factors which can be used as markers for specific neural
populations. Some of these interneuron populations, identified via developmental
genetics, have been shown to play similar roles to some of the neural populations
described in locomotor networks controlling swimming. Specified by the transcription
factor Dbx1, commissurally projecting inhibitory V0 interneurons are necessary for
left-right alternation during mammalian locomotion (Lanuza et al., 2004). V1
interneuons, specified by the transcription factor En1, are ipsilaterally projecting
inhibitory interneurons that regulate the speed of locomotion (Gosgnach et al., 2006).
V2a interneurons, specified by the transcription factor Chx10, are involved in the
left-right coordination during locomotion via their ipsilateral glutamatergic projections
onto commissural interneurons such as V0 interneurons (Crone et al., 2008).
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Ipsilaterally projecting excitatory V3 interneurons, specified by the transcription factor
Sim1, help to balance robust network excitation required in rhythmically active spinal
locomotor networks (Zhang et al., 2008). Other populations of spinal interneurons
will likely be revealed as additional transcription factors responsible for the
differentiation of spinal neurons are identified. However, the possibility that identified
neural populations include heterogeneous neuronal subsets must always be considered,
in order to reach a full understanding of locomotor CPG networks in the mammalian
spinal cord. Nevertheless, any neural signals generated by locomotor CPG networks
finally converge onto spinal motoneurons where integration, modulation and
determination of the final locomotor network output takes place.
Spinal motoneurons
Motoneurons that innervate limb muscles are referred to as the final common
pathway of motor networks of the CNS (Sherrington, 1947). Anatomically, cell bodies
of spinal motoneurons form a nucleus at the ventrolateral corner, mostly in lamina IX,
of the ventral horn of the spinal cord. Cell bodies of motoneurons are somatotopically
organised within each motor nucleus (Nicolopoulos-Stournaras & Iles, 1983), such that
those found in the medial part of lamina IX innervate muscles of the trunk, whereas
those found in the dorsolateral and ventrolateral parts innervate muscles of distal and
proximal limbs respectively. The diameter of motoneuron cell bodies is typically 2 – 3
times larger than other neuron types found in the spinal cord, for example the soma
diameter of motoneurons that control muscles of the hind limb in cats can be up to 70
μm (Zwaagstra & Kernell, 1981).   
Spinal motoneurons should not be regarded as simple relay neurons that passively
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transmit rhythmic locomotor signals generated from pre-motor CPG networks to the
muscles they innervate. Motoneurons in fact play important roles in neural processes
such as integration of rhythmic pre-motor locomotor signals and modulation of the final
motor output generated by whole spinal locomotor networks. Spinal motoneurons
receive cohorts of mixed excitatory and inhibitory locomotor command signals
produced by pre-motor CPG networks via activation of fast acting ionotropic receptors,
such that excitatory signals are primarily mediated via glutamatergic transmission while
inhibitory signals are mediated via GABAergic and glycinergic transmission (Shefchyk
& Jordan, 1985; Orsal et al., 1986; Cazalets et al., 1996; Hochman & Schmidt, 1998).
Concurrently, spinal motoneurons also receive a wide variety of other chemical signals
(including monoamines, peptides, and acetylchonine to name but a few) which mediate
neuromodulatory signals via the activation of slower acting G-protein coupled
metabotropic receptors (Rekling et al., 2000). In addition, although glutamate is the
major fast excitatory neurotransmitter within locomotor networks of the spinal cord
(Beato et al., 1997; Whelan et al., 2000; Talpalar & Kiehn, 2010), glutamate can also
act as an important neuromodulator for spinal locomotor networks, including
motoneurons, by activating its metabotropic receptors (El Manira et al., 2002; Nistri et
al., 2006; El Manira et al., 2008).
Modulation of spinal locomotor networks
Due to their G-protein coupled nature and slow mode of action, metabotropic
receptors, not only of glutamate but also of other neurotransmitters, play significant
roles in the modulation of a wide range of neural networks throughout the nervous
system. Locomotor networks within the spinal cord are, of course, no exception and
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are modulated by a number of neuromodulatory signals acting via metabotropic
receptors. This diverse neuromodulation allows the fundamental behaviour,
locomotion, to be flexible and adaptable to meet varied physiological demands. These
include the demands of different internal metabolic states, developmental stages and
external stimuli from ever changing environments. Most neuromodulatory signals to
spinal locomotor networks originate from ‘extrinsic’ supra-spinal systems, in particular
descending monoaminergic inputs from distinct nuclei of the brainstem (Rekling et al.,
2000; Schmidt & Jordan, 2000; Grillner, 2006; Heckman et al., 2009). These extrinsic
modulatory inputs from the brainstem to spinal locomotor networks often reflect an
animal’s sleep-wake cycle, and attentional or motivational states (Rekling et al., 2000;
Grillner, 2006). These descending inputs from the brainstem also play important roles
in the development of locomotor networks in the foetal and neonatal mammalian spinal
cord. For example, serotonergic projections from the raphe nuclei are one of the first
descending projections that reach the lumbar enlargement of the rat spinal cord during
the late foetal period (Bregman, 1987; Rajaofetra et al., 1989). This is the
developmental period when rat spinal locomotor networks start to exhibit left-right
alternating activity rather than synchronous activity (Iizuka et al., 1998). Through the
early neonatal period, the presence of 5-HT then helps refine left-right alternation of
locomotor activity produced by spinal networks (Norreel et al., 2003; Pearlstein et al.,
2005).
However, it has been demonstrated that there are also other neuromodulatory inputs
to spinal motor networks that arise ‘intrinsically’ from local intra-spinal networks,
which activate, for example, cholinergic, glutamatergic or purinergic receptors, to
modulate networks of which they are intrinsic components (Dale & Gilday, 1996; Katz
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& Frost, 1996; Rekling et al., 2000; Alaburda & Hounsgaard, 2003; Miles et al., 2007;
El Manira et al., 2008; Zagoraiou et al., 2009). Cholinergic pre-motor terminals of
local spinal interneurons called C-boutons are known to modulate input-output
relationships of motoneurons via postsynaptic activation of G-protein coupled
muscarinic receptors (Miles et al., 2007; Zagoraiou et al., 2009). Perhaps
unsurprisingly, since glutamate is the major fast excitatory neurotransmitter within
locomotor CPG networks in the spinal cord (Beato et al., 1997; Whelan et al., 2000;
Talpalar & Kiehn, 2010), glutamate can also act as one of the most widely available
intrinsic neuromodulators for neural components within spinal locomotor networks,
including motoneurons, via activation of its metabotropic receptors (El Manira et al.,
2002; Nistri et al., 2006; El Manira et al., 2008).
Metabotropic glutamate receptors
Glutamate is one of 20 amino acids that make up the proteins of biological systems.
However it also exists as one of the major excitatory neurotransmitters found in the
CNS. Glutamate receptors are very broadly divided into two types based on their
biochemical mode of actions, ion channel coupled ionotropic glutamate receptors
(iGluRs) and G-protein coupled metabotropic glutamate receptors (mGluRs). iGluRs
include NMDA, AMPA, and kainate receptors, named after their specific
pharmacological agonists. Due to their classic role mediating fast excitatory
neurotransmission, iGluRs have long been the focus of extensive research. On the
other hand, mGluRs were first reported in the late 1980s as new types of glutamate
receptors (Sugiyama et al., 1987) but remain less understood compared to iGluRs. To
date, there are 8 subtypes of mGluRs identified, mGluR1 to mGluR8 subtypes, which
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are normally divided into 3 groups, group I, II, and III, according to their molecular
homology, pharmacological profiles and coupled biochemical intracellular signalling
(Pin & Duvoisin, 1995; Conn & Pin, 1997; Anwyl, 1999, 2009).
Because of the wide variety of intracellular cascades affected by the activation of
mGluRs, these receptors are important players in neuromodulation of intrinsic neural
properties and the efficacy of synaptic transmission throughout the CNS. Group I
mGluRs, including mGluR1 and mGluR5 subtypes, are Gq ptotein coupled
metabotropic receptors, which are positively coupled to phospholipase C (PLC),
resulting in catalysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into diacyl
glycerol (DAG) and inositol triphosphate (IP3). Group II mGluRs, consisting of
mGluR2 and mGluR3 subtypes, and group III mGluRs, namely mGluR4, mGluR6 to
mGluR8 subtypes, are Gi protein coupled metabotropic receptors that inhibit production
of cAMP via blockade of adenylate cyclase. In the CNS in general, group I mGluRs
facilitate neuronal excitation via postsynaptic mechanisms (Anwyl, 1999, 2009). On
the other hand, group II and III mGluRs are often found to be inhibitory at pre-synaptic
terminals (Anwyl, 1999, 2009) for example acting as autoreceptors to inhibit
pre-synaptic glutamate release (Chen et al., 2002; Mateo & Porter, 2007). Group I
mGluRs are also reported to have pre-synaptic actions. In the lamprey spinal cord, for
example, activation of group I mGluRs leads to an increase in intracellular Ca2+
concentration at pre-synaptic terminals (Schwartz & Alford, 2000), which is followed
by potentiation of pre-synaptic glutamate release (Takahashi & Alford, 2002).
Group I mGluRs and modulation of spinal locomotor networks
Neuromodulatory roles of mGluRs in spinal locomotor networks have previously
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been studied in vertebrate animals such as lampreys (El Manira et al., 2002; El Manira
et al., 2008), Xenopus tadpoles (Chapman & Sillar, 2007; Chapman et al., 2008) and
rats (Nistri et al., 2006). The modulatory roles of group I mGluRs have been most
extensively studied in isolated spinal cord preparations obtained from lampreys. In
these preparations, endogenous activation of group I mGluRs is reported, which
supports the importance of group I mGluRs in the modulation of locomotor networks in
the lamprey spinal cord (Krieger et al., 1998; Krieger et al., 2000; Kettunen et al., 2002).
Exogenous activation of group I mGluRs causes both short- and long-term modulation
of lamprey locomotor networks, increasing locomotor-related burst frequency recorded
from ventral roots of in vitro spinal cord preparations (Krieger et al., 1998; Krieger et
al., 2000; Kyriakatos & El Manira, 2007). Group I mGluR-mediated modulation of
locomotor network activity likely involves modulation of synaptic transmission within
spinal locomotor networks, such that inhibitory synaptic transmission is depressed
(Kettunen et al., 2005; Kyriakatos & El Manira, 2007) and excitatory transmission to
spinal motoneurons is enhanced (Kyriakatos & El Manira, 2007). In addition, group I
mGluR-mediated modulation of synaptic transmission involves retrograde modulatory
mechanisms mediated via endocannabioid and nitric oxide signalling (Kettunen et al.,
2005; Kyriakatos & El Manira, 2007).
Beyond the modulation of locomotor network activity, cellular properties that are
modulated by group I mGluR activation have also been well characterised in spinal
neurons of lampreys. The activation of group I mGluRs results in depolarisation of the
resting membrane potential (Krieger et al., 1998; Kettunen et al., 2003), which is
mediated via blockade of leak currents in a PKC dependent manner (Kettunen et al.,
2003; Nanou et al., 2009). The activation of group I mGluRs also causes oscillations
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in intracellular Ca2+ levels, requiring Ca2+ entry through L-type but not N-type Ca2+
channels (Kettunen et al., 2002). Furthermore, the activation of group I mGluRs is
reported to modulate activities of iGluRs, for example enhancing currents mediated by
NMDA receptors (Krieger et al., 1998; Krieger et al., 2000; Nanou et al., 2009) as well
as affecting AMPA-induced Na+ activated K+ currents (Nanou & El Manira, 2010).
Compared to studies performed in lamprey in vitro spinal cord preparations, less
detailed analyses of the modulatory roles of group I mGluRs have been performed in
the mammalian spinal cord, and these mammalian studies are so far limited to those
conducted on in vitro spinal cord preparations obtained from neonatal rats.
Endogenous activation of group I mGluRs has been demonstrated in rat spinal cord
preparations by the application of group I mGluR antagonists, which reduce the
frequency of rhythmic locomotor-related burst activity recorded from lumbar ventral
roots of in vitro spinal cord preparations (Taccola et al., 2004). However, application
of a group I mGluR agonist also slows the frequency of locomotor bursts, although a
high dose of this agonist rapidly disrupts the rhythm of locomotor network activity
(Taccola et al., 2004). The effects of group I mGluR activation upon synaptic
transmission within the rat spinal cord are also diverse as evidenced by reports of both
enhancement and depression of inhibitory synaptic transmission to spinal motoneurons
(Marchetti et al., 2003, 2005). Cellular properties are also modulated by the activation
of group I mGluRs in rat spinal motoneurons to cause membrane depolarisation and
oscillations in the resting membrane potential (Marchetti et al., 2003). It therefore
seems that the modulatory roles of group I mGluRs in mammalian spinal locomotor
networks are complicated and not yet fully understood. Thus further investigation of the
roles and mechanisms of group I mGluR-mediated modulation are warranted in the
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mammalian spinal cord.
Amyotrophic Lateral Sclerosis
One clinical condition that affects locomotor networks in the spinal cord is the
motoneuron disease, amyotrophic lateral sclerosis (ALS). ALS is also known as Lou
Gehrig’s disease in some countries after a baseball player who suffered from it. ALS
is a fatal neurodegenerative disease in which motoneurons are selectively lost due to
unknown causes and via undefined mechanisms. It is estimated that ALS affects 2 in
100,000 people per year. 90 % of all ALS cases are sporadic (no known causes), and
the remaining 10 % are familial cases (hereditary genetic causes). 20 % of familial
ALS cases involve genetic defects in the gene encoding an enzyme, superoxide
dismutase-1 (SOD-1). The onset of ALS is sudden, typically at middle age (late 30s –
early 50s). Disease progression is characterised by rapid and selective degeneration of
motoneurons in the brainstem and spinal cord, which severely impairs patients’ motor
functions. Most patients die of breathing difficulties due to paralysis of their
respiratory muscles within 2 - 3 years of diagnosis. No significant treatments are
available for ALS. The only approved treatment is the administration of a drug,
riluzole, which only provides modest prolongation of patients’ life, approximately 3
months. A number of hypotheses for understanding the pathogenesis of ALS have
been proposed. These include mitochondrial dysfunction, cellular oxidative stress,
disorganisation of neurofilaments, toxicity from intracellular aggregates, and
glutamatergic excitotoxicity (Bruijn et al., 2004; Boillee et al., 2006). However, these
various proposed mechanisms are unlikely to be mutually exclusive, probably all
converging to cause the final death of motoneurons.
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Glutamatergic excitotoxicity
Although ALS is a multi-factorial neurodegenerative disease, the hypothesis that
glutamatergic excitotoxicity is involved in the pathogenesis of ALS seems to have
received the most support. Firstly, an elevated concentration of glutamate in
cerebrospinal fluid is reported in 40 % of ALS patients (Spreux-Varoquaux et al., 2002).
Secondly, the astroglial glutamate transporter, excitatory amino acid transporter 2
(EAAT2), which is responsible for removal of glutamate from synaptic spaces, is
reported as having reduced expression in ALS patients (Rothstein et al., 1995; Fray et
al., 1998) and also in ALS model mice (Bruijn et al., 1997). Finally, riluzole, the only
drug clinically approved for the treatment of ALS, is thought to inhibit glutamate
release (Doble, 1996). Thus, evidence points strongly towards glutamatergic
excitotoxicity, initiated not only by an excessive release of glutamate into extracellular
spaces but also by abnormal clearance of glutamate from extracellular spaces, as
playing a key role in the pathology of ALS.
Glutamatergic excitotoxicity in ALS is mostly discussed in the context of
iGluR-mediated Ca2+ influx and the subsequent disturbance of intracellular Ca2+
homeostasis in motoneurons (Arundine & Tymianski, 2003; Van Den Bosch et al.,
2006). Initiated by an excessive amount of glutamate present in the extracellular space,
glutamatergic excitotoxicity is a vicious circle of intracellular biochemical
consequences that ends in degeneration of motoneurons. Over-activation of iGluRs,
especially NMDA receptors and Ca2+ permeable AMPA receptors, allows huge influx of
Ca2+ ions from the extracellular space. As Ca2+ ions are important in a range of
cellular processes, the homeostasis of intracellular Ca2+ needs to be tightly regulated
under physiological conditions. However, disturbances in intracellular Ca2+
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homeostasis, particularly abnormally elevated intracellular Ca2+ levels, lead to excessive
activation of many Ca2+ dependent catalytic processes, for example those activating
proteases, lipases, phosphatases, and endonucleases. These enzymes mediate reactions
which breakdown the physical structures of motoneurons, and mediate the formation of
oxidative free radicals which also favour the death motoneurons.
Group I mGluRs and ALS
In contrast to the well-documented roles of iGluRs in glutamatergic excitotoxicity
(Arundine & Tymianski, 2003; Van Den Bosch et al., 2006) and despite the fact that
group I mGluRs are suggested to increase intracellular Ca2+ levels in spinal
motoneruons (Kettunen et al., 2002), whether group I mGluRs are involved in the
excitotoxic pathogenesis of ALS remains uncertain. Molecular expression of group I
mGluRs is comparable in motoneurons of the spinal cord between control subjects and
ALS patients (Aronica et al., 2001; Valerio et al., 2002) but elevated expression of
group I mGluRs is reported in glial cells in the ALS affected spinal cord (Aronica et al.,
2001). Subtypes of group I mGluRs seem to be differentially expressed in different
motoneuron nuclei showing varied susceptibility to neurodegeneration in ALS. In the
brainstem and spinal cord, mGluR1 subtypes are expressed to a lesser degree in
vulnerable motor nuclei, whereas mGluR5 subtypes are expressed at higher levels in
resistant motor nuclei (Laslo et al., 2001; Anneser et al., 2004; Ma et al., 2006). Such
differential expression of group I mGluR subtypes may explain mixed evidence that
group I mGluRs play both neuroprotective and neurotoxic roles in glutamate-induced
neurotoxicity depending on different experimental conditions. Application of group I
mGluR agonists prevents kainate-induced neuronal death in spinal cord slices obtained
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from adult rats (Pizzi et al., 2000; Valerio et al., 2002). However, application of either
an agonist or an antagonist of group I mGluRs prevents neuronal death in embryonic
chick spinal cell cultures treated with CSF obtained from human ALS patients (Anneser
et al., 2006). Given the uncertainty regarding the potential neuroprotective or
neurotoxic roles of group I mGluRs in glutamatergic excitotoxicity, it is important to
assess the physiological effects of group I mGluR activation or inhibition in nervous
tissues that are affected by ALS.
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Chapter 2
The role of group I metabotropic glutamate
receptors (mGluRs) in locomotor network
activity in the mouse spinal cord
Parts of the following chapter have been published in:
Iwagaki, N. and Miles, GB. (2011)
Activation of group I metabotropic glutamate receptors modulates
locomotor-related motoneuron output in mice
J Neurophysiol. 105 (5) : 2108 - 20.
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Introduction
Modulation of spinal locomotor networks is important for animals to adapt their
motor behaviours in response to variable environmental stimuli and physiological states
such as metabolism or development. In many cases, modulatory inputs to locomotor
networks in the spinal cord come from supra-spinal systems, for example descending
serotonergic or noradrenergic inputs to spinal networks originate from distinct nuclei in
the brainstem (Rekling et al., 2000; Schmidt & Jordan, 2000; Heckman et al., 2009).
However, there is also evidence of intrinsic neuromodulatory inputs that come from
neural networks within the spinal cord (Dale & Gilday, 1996; Katz & Frost, 1996;
Alaburda & Hounsgaard, 2003; El Manira et al., 2008; Zagoraiou et al., 2009). In
spinal locomotor networks, glutamate is released as a major neurotransmitter that
mediates fast excitatory neurotransmisson (Beato et al., 1997; Whelan et al., 2000;
Talpalar & Kiehn, 2010). However glutamate can also act as an important intrinsic
neuromodulator that activates metabotropic receptors (El Manira et al., 2002; Nistri et
al., 2006; El Manira et al., 2008).
The modulatory roles of metabotropic glutamate receptors (mGluRs), particularly
group I mGluRs, in vertebrate spinal locomotor networks are best described in lamprey
in vitro spinal cord preparations in which rhythmic left-right alternating bursts of
swimming-related activity are recorded from ventral roots. The activation of group I
mGluRs leads to both short- and long-term increases in the frequency of
locomotor-related ventral root bursts (Krieger et al., 1998; Kyriakatos & El Manira,
2007), which reflects depression of inhibitory synaptic transmission (Kettunen et al.,
2005; Kyriakatos & El Manira, 2007) and also enhancement of excitatory transmission
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to motoneurons (Kyriakatos & El Manira, 2007). Both the short- and long-term
increases in locomotor burst frequency depend on endocannabioid signalling, which
retrogradely modulates both excitatory and inhibitory synaptic transmission to spinal
motoneurons (Kettunen et al., 2005; Kyriakatos & El Manira, 2007). In addition,
long-term, but not short-term, enhancement of excitatory neurotransmission requires
signalling mediated by the release of nitric oxide (Kyriakatos & El Manira, 2007).
Similar modulation of spinal locomotor networks by group I mGluRs has also been
reported on bursts of fictive swimming recorded from ventral roots of immobilised
Xenopus tadpole preparations (Chapman & Sillar, 2007; Chapman et al., 2008). The
activation of group I mGluRs causes an increase in the frequency of swimming-related
ventral root bursts (Chapman & Sillar, 2007). This increase in swimming burst
frequency is mediated via depression of inhibitory glycinergic transmission (Chapman
et al., 2008).
Investigations into the modulation of mammalian spinal locomotor networks are so
far limited to studies using in vitro spinal cord preparations obtained from neonatal rats.
However, the modulatory roles of group I mGluRs in rat spinal locomotor networks
appear to be complicated, with the application of either group I mGluR agonists or
antagonists both reducing the frequency of locomotor-related burst activity recorded
from lumbar ventral roots (Taccola et al., 2004). Moreover, the application of a group
I mGluR agonist at higher doses completely disrupts rhythmic bursts of spinal
locomotor activity (Taccola et al., 2004). Effects of group I mGluR activation upon
synaptic transmission within the rat spinal cord also seem diverse, since data support
both inhibition (Marchetti et al., 2003) and enhancement (Marchetti et al., 2005) of
inhibitory synaptic transmission.
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Given the complexities and unsolved roles of group I mGluRs in mammalian spinal
locomotor networks, the present study aimed to investigate effects of group I mGluR
activation on rhythmic locomotor-related ventral root activity recorded from in vitro
spinal cord preparations obtained from neonatal mice. Although the activation of
group I mGluRs has been demonstrated to modulate locomotor burst frequency in rats,
Xenopus tadpoles and lampreys, it remains to be determined whether the activation of
group I mGluRs also modulates the intensity of rhythmic burst activity produced by
spinal locomotor networks. Therefore a key focus of the present chapter is to
determine the effects of group I mGluR activation on the intensity of locomotor-related
motoneuron output. Furthermore, it is assessed which receptor subtypes of group I
mGluRs (mGluR1 versus mGluR5) are specifically involved in the modulation of
mammalian spinal locomotor networks. Finally, it is investigated whether the group I
mGluR-mediated modulation of locomotor networks within the mouse spinal cord
requires downstream effects that are dependent on endocannabinoid or nitric oxide
signalling, as has been demonstrated in locomotor networks in the lamprey spinal cord
(Kettunen et al. 2005; Kyriakatos and El Manira 2007).
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Methods
In vitro mouse spinal cord preparations
All methods required to obtain tissue for in vitro experiments were conducted in
accordance with the UK Animals (Scientific Procedures) Act 1986. In vitro whole
spinal cord preparations were obtained from post natal day (P) 2 – 6 C57BL/6 mice,
using techniques similar to those described by Jiang et al. (1999). Animals were killed
via cervical dislocation, decapitated and eviscerated before spinal cords were isolated
from the mid-cervical to upper sacral segments in a chamber containing artificial
cerebral spinal fluid (aCSF; equilibrated with 95 % O2 – 5 % CO2, ~4 ˚C).  The dura 
matter was removed for the purpose of assisting diffusion of chemicals to the
preparations.
Ventral root recordings
Glass suction electrodes were attached to lumbar (L) 1 or L2 ventral roots of in vitro
spinal cord preparations (Fig. 1A). NMDA (5 M), 5-HT (10 M) and dopamine (50
M) were added to the aCSF to induce rhythmic, left-right alternating bursts of
locomotor-related ventral root activity (Jiang et al., 1999; Miles et al., 2007; Fig. 1B).
Unless noted otherwise, locomotor-related bursts were left to stabilise (~1 hour) before
subsequent drug applications. Raw signals were amplified and filtered (30 – 3,000 Hz;
Qjin Design, ON, Canada), before being acquired at ≥ 1 kHz using a Digidata 1440A 
A/D board and AxoScope software (Molecular Devices, Sunnyvale, CA). These raw
signals were also rectified and integrated online (Qjin Design) for subsequent analyses
of ventral root bursts.
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Figure 1: Rhythmic locomotor-related burst activity recorded from an in vitro 
mouse spinal cord preparation.  
A) Schematic diagram of an in vitro mouse spinal cord preparation (courtesy of G. 
B. Miles, University of St Andrews).  Extracellular recording suction electrodes 
were attached to the left and right first or second lumbar (L1 or L2) ventral roots.  
B) Raw (top) and integrated and rectified (bottom) traces showing rhythmic loco-
motor burst activity induced by pharmacological agents (5 µM NMDA, 10 µM 
5-HT, and 50 µM dopamine).  Amplitude and frequency of locomotor bursts were 
measured for analyses. 
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Data analysis
Data from ventral root recordings were analysed offline using Dataview software
(courtesy of W. J. Heitler, University of St Andrews). To detect ventral root bursts, a
threshold was set near to the bottom of rectified and integrated traces. The beginning
and end of ventral root bursts were defined as points where the integrated traces
positively and negatively crossed the threshold. The amplitude of ventral root bursts
was measured from the baseline, threshold value to the peak value of bursts (Fig. 1B).
The reciprocal of the interval between the start of two adjacent bursts was defined as the
instantaneous frequency (Fig. 1B). Values of burst amplitude and frequency were
normalised by dividing them by averaged values of amplitude and frequency recorded
for 5 minutes before control (pre-control values). Data are reported as mean ± S.E.
Differences in means between control and drug conditions were compared using
Student’s t-tests. Values of p < 0.05 were considered significant.
Solution and drugs
The standard aCSF solution used for dissection and recordings contained 127 mM
NaCl, 3 mM KCl, 1.3 mM NaH2PO4, 1 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, and
10 mM D-glucose (equilibrated with 95 % O2 – 5 % CO2). Pharmacological agents
used included: NMDA (N-methyl-D-aspartic acid), 5-HT (5-hydroxytryptamine hydro-
chloride), dopamine (3,4-dihydroxyphenethylamine hydrochloride), and PTIO
(2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide) purchased from Sigma-
Aldrich (St Louis, MO); DHPG ((S)-3,5-dihydroxyphenylglycine), LY367385
((S)-(+)-a-amino-4carboxy-2-methylbenzeneacetic acid), MPEP (2-methyl-6(phenyl-
ethynyl)pyridine hydrochloride), and AM251 (N-(piperidin-1-yl)-5-(4-iodophenyl)-
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1-(2,4-dichlorophenyl)4-methyl-1H-pyrazole-3-carboxamide) purchased from Tocris
Bioscience (Bristrol, UK); and L-NAME (Nω-Nitro-L-arginine methyl ester 
hydrochloride) purchased from Ascent Scientific (Bristrol, UK).
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Results
Group I mGluR-mediated modulation of spinal locomotor networks
Locomotor drugs (5 µM NMDA, 10 µM 5-HT, 50 µM dopamine) were added to the
recording aCSF to induce rhythmic, left-right alternating bursts of locomotor-related
ventral root activity in mouse in vitro spinal cord preparations. The group I mGluR
agonist, DHPG (5 – 50 M), was then bath applied to investigate whether the activation
of group I mGluRs modulates spinal locomotor-related burst activity. The application
of DHPG (5 µM; 15 min) led to a significant decrease in the amplitude of
locomotor-related burst activity recorded from lumbar ventral roots (Fig. 2A & 2B).
The amplitude of locomotor bursts decreased gradually, reaching the minimum level
near the end of the 15 minute DHPG application (18.0 ± 4.0 % reduction, n = 11, p <
0.001; Fig. 2Bi & 2Bii), before returning to control levels within ~10 minutes of drug
washout (Fig. 2Bi). Analyses of baseline ventral root activity between locomotor
bursts (inter-burst activity) revealed no change in the baseline activity upon DHPG
application (n = 11; Fig. 2C). The application of DHPG also caused a significant
increase in the frequency of locomotor burst activity (Fig. 2A & 2D). Locomotor burst
frequency increased gradually, peaking near the end of the 15 minute DHPG application
(23.0 ± 8.8 % increase, n = 11, p = 0.008; Fig. 2Di & 2Dii), before returning to control
levels within ~10 minutes of drug washout (Fig. 2Di). Together these data
demonstrate that the activation of group I mGluRs modulates on-going locomotor
output driven by spinal motor networks.
Given that group I mGluR activation has long-term effects on locomotor burst
activity recorded from in vitro lamprey spinal cord preparations (Kyriakatos & El
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Figure 2: Group I metabotropic glutamate receptors (mGluRs) modulate
locomotor burst activity recorded from in vitro mouse spinal cord preparations.
A) Raw (top) and rectified and integrated (bottom) traces showing the effects of the
group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG; 5 M) on spinal
locomotor burst activity. Bi) DHPG application (15 min) reduced the amplitude of
locomotor bursts. Each point in the time-course plots represents 1 min worth of
recording, normalized to control (5 M, n = 11; 10 M, n = 9). Bii) Pooled data,
averaged from 5 min worth of recording in each experimental condition, show a
significant decrease in locomotor burst amplitude in response to DHPG application (5
M). Ci) Time course plot and Cii) pooled data showing no significant effect of
DHPG application (5 M) on baseline inter-burst activity of ventral roots. Di) DHPG
application (5 M and 10 M) increased the frequency of locomotor bursts. Dii)
Pooled data showing a significant increase in locomotor burst frequency by DHPG
application (5 M). * = significantly different from control.
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Figure 3: Different conditions of DHPG application.
A) A high dose of DHPG (50 M) disrupted rhythmic locomotor activity recorded from
lumbar ventral roots of in vitro mouse spinal cord preparations. B) Neither DHPG
alone (10 M) nor DHPG in combination with NMDA (5 M) application was able to
induce rhythmic locomotor burst activity in an in vitro mouse spinal cord preparation.
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Manira, 2007), it was assessed whether higher doses of DHPG might have long-term
effects in mouse in vitro spinal cord preparations. Application of 10 µM DHPG (n =
9) again led to a significant decrease in locomotor burst amplitude and a significant
increase in locomotor burst frequency (Fig. 2Bi & 2Di), with both effects of equivalent
magnitude to those observed following 5 µM DHPG application. Although the effects
of 10 µM DHPG application slightly outlasted those of 5 µM application, no long-term
effects were observed (Fig. 2Bi & 2Di). DHPG at higher doses (20 – 50 µM) also
decreased the amplitude of locomotor bursts. However, this was accompanied by a
rapid disruption in locomotor output, where rhythmic burst activity ceased several
minutes after the start of drug application (Fig. 3A).
Since apparent excitatory effects of group I mGluR activation were observed on the
frequency of locomotor burst activity generated from spinal CPG networks, it was also
investigated whether DHPG (10 µM) alone or DHPG in combination with NMDA (5
µM) application could elicit rhythmic locomotor burst activity. Although DHPG
application increased baseline tonic activity recorded from lumbar ventral roots, no
rhythmic locomotor bursts were observed under these conditions (n = 3; Fig. 3B).
Together these results demonstrate that, although group I mGluR activation cannot
induce spinal locomotor activity, it does modulate on-going activity generated by
locomotor networks in two ways. Firstly, the activation of group I mGluRs reduces the
intensity of the final locomotor output produced by spinal motoneurons, and secondly,
the activation of group I mGluRs speeds up the rhythm of locomotor activity mediated
by interneurons that make up spinal locomotor CPGs.
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Group I mGluR subtype-specific modulation of spinal locomotor networks
The group I mGluR specific agonist DHPG equally activates both mGluR1 and
mGluR5 subtypes. Thus, the activation of either receptor subtype could be responsible
for the effects of DHPG application on spinal locomotor networks. To determine
which receptor subtypes are involved, and to assess whether there is endogenous
activation of group I mGluRs in mouse in vitro spinal cord preparations, mGluR1
(LY367385) and mGluR5 (MPEP) subtype-specific antagonists were utilised. Each
antagonist was applied for 30 minutes prior to, and then together with the application of
DHPG (5 µM, 15 min; Fig. 4).
Application of the mGluR1 antagonist, LY367385 (50 µM), alone had no significant
effects on the amplitude or frequency of locomotor-related ventral root bursts (n = 7;
Fig. 4A & 4B). However, the application of LY367385 blocked the decrease in burst
amplitude and increase in burst frequency normally induced by DHPG application (Fig.
4A & 4B). Application of the mGluR5 antagonist, MPEP (50 µM), also had no
significant effects on locomotor burst activity when applied alone (n = 6; Fig. 4C & 4D).
MPEP application did, however, block the DHPG-induced decrease in locomotor burst
amplitude (Fig. 4C), but had no effect on the increase in locomotor burst frequency
induced by DHPG application (31.5 ± 6.4 % increase, n = 6, p = 0.002; Fig. 4D).
Given that LY367385 is a competitive mGluR1 antagonist, it is possible that an
endogenous role for mGluR1 subtypes was not uncovered due to weak competition of
the antagonist with endogenous glutamate present within spinal networks. To address
this issue, the in vitro spinal cord preparations were pre-incubated in LY367385 (50
µM) prior to the induction of locomotor burst activity, and then LY367385 was
subsequently washed out while locomotor activity was still on-going. In these
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Figure 4: Receptor subtype-specific effects of group I mGluR activation on
locomotor burst activity.
Ai) Time course plot shows that the mGluR1 antagonist LY367385 (50 M) blocked the
DHPG (5 M)-mediated decrease in locomotor burst amplitude. Aii) Pooled data,
averaged over 5 min worth of recording in each experimental condition (control,
subtype-specific antagonist, subtype-specific antagonist plus DHPG, and drug washout)
show that DHPG application had no significant effect on locomotor burst amplitude in
the presence of LY367385 (n = 7). Bi) Time course plot shows that LY367385 also
blocked the DHPG-mediated increase in locomotor burst frequency. Bii) Pooled data
show no significant effect of DHPG application on locomotor burst frequency in the
presence of LY367385. Ci) Time course plot shows that the mGluR5 antagonist MPEP
(50 M) also blocked the DHPG-mediated decrease in locomotor burst amplitude.
Cii) Pooled data show no significant effect of DHPG application on locomotor burst
amplitude in the presence of MPEP (n = 6). Di) Time course plot shows that MPEP
did not, however, block the DHPG-mediated increase in locomotor burst frequency.
Cii) Pooled data show a significant increase in locomotor burst frequency in response to
DHPG application even in the presence of MPEP. * = significantly different from
control.
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Figure 5: Assessment of the potential pharmacological competition between 
endogenous glutamate and the competitive mGluR1 antagonist LY367385.  
Ai) Time course plot and Aii) pooled data show there was no significant change in 
locomotor burst amplitude upon the washout of LY367385 (50 µM), when the drug 
was included in the recording solution prior to and during the pharmacological 
induction of locomotor activity (n = 3).  Bi) Time course plot and Bii) pooled data 
show there was also no significant difference in locomotor burst frequency upon 
the washout of LY367385.  
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experiments, LY367385 again had no effects on the amplitude or frequency of
locomotor burst activity (n = 5; Fig. 5A & 5B).
Together these results suggest that group I mGluRs are not endogenously activated
during locomotor activity recorded in vitro from isolated mouse spinal cord preparations.
However once stimulated, group I mGluRs modulate the locomotor activity driven by
spinal networks. mGluR1 subtypes are involved in the modulation of both the
amplitude and frequency of rhythmic locomotor burst activity. However, mGluR5
subtypes are involved in the modulation of locomotor burst amplitude but not
frequency.
Analysis of signalling pathways downstream of group I mGluR activation
Modulation of spinal locomotor activity by the activation of group I mGluRs
involves downstream effects that are mediated via endocannabinoid and nitric oxide
signalling in lamprey in vitro spinal cord preparations (Kettunen et al., 2005; Kyriakatos
& El Manira, 2007). It was therefore assessed whether similar signalling mechanisms
were required for the group I mGluR-mediated modulation of locomotor activity in
mouse in vitro spinal cord preparations. An endocannabinoid receptor antagonist and
pharmacological blockers of nitric oxide signalling were utilised to examine whether the
group I mGluR-mediated modulation of spinal locomotor activity was occluded when
these signalling pathways were blocked.
To assess involvement of endocannabinoid signalling, rhythmically active in vitro
spinal cord preparations were bathed in recording aCSF that contained the
endocannabinoid CB1 receptor antagonist, AM251 (5 M). The application of DHPG
(5 µM) in the presence of AM251 still led to a significant decrease in the amplitude of
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Figure 6: Involvement of endocannabinoid or nitric oxide signalling in group I
mGluR-mediated modulation of locomotor activity.
Ai) Time course plot shows that the CB1 receptor antagonist AM251 (5 M) did not
block the DHPG (5 M)-mediated decrease in locomotor burst amplitude. Aii) Pooled
data show that DHPG application still significantly reduced locomotor burst amplitude
in the presence of AM251 (n = 6). Bi) Time course plot shows that AM251 also did
not block the DHPG-mediated increase in locomotor burst frequency. Bii) Pooled data
show a significant increase in locomotor burst frequency by DHPG application in the
presence of AM251. Ci) Time course plot shows that nitric oxide signalling blockers
(L-NAME 200 M and PTIO 400 M) also did not block the DHPG-mediated decrease
in locomotor burst amplitude. Cii) Pooled data show a significant decrease in
locomotor burst amplitude by DHPG application in the presence of nitric oxide
signalling blockers (n = 6). Di) Time course plot shows that nitric oxide signalling
blockers again did not block the DHPG-mediated increase in locomotor burst frequency.
Dii) Pooled data show a significant increase in locomotor burst frequency in response to
DHPG application in the presence of nitric oxide blockers. * = significantly different
from control.
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locomotor bursts (13.7 ± 5.7 % decrease, n = 6, p = 0.033; Fig. 6A) and also an increase
in locomotor burst frequency (82.4 ± 39.7 % increase, n = 6, p = 0.024; Fig. 6B). The
degree to which DHPG application reduced locomotor burst amplitude in the presence
of AM251 was similar to that observed in the standard aCSF. However, the
DHPG-induced increase in locomotor burst frequency was approximately 4 times
greater, but far more variable, in the presence of AM251, compared to in the standard
aCSF. This was likely to be due to greater variability in the control locomotor
frequency recorded from in vitro spinal cord preparations incubated in AM251, as was
also reported in lamprey in vitro spinal cord preparations (Kettunen et al., 2005).
Although these data suggest that endogenous activation of CB1 receptors may be
required for stable generation of rhythmic locomotor activity, endocannabinoid
signalling mediated via CB1 receptors is not required for group I mGluR-mediated
modulation of locomotor networks in the mouse spinal cord.
Next, to examine involvement of nitric oxide signalling in group I mGluR-mediated
modulation of spinal locomotor activity, the general nitric oxide synthase inhibitor,
L-NAME (200 M), and the nitric oxide scavenger, PTIO (400 M), were included in
the recording aCSF that perfused rhythmically active in vitro spinal cord preparations.
Despite the presence of L-NAME and PTIO, the application of DHPG (5 M) again led
to a significant decrease in locomotor burst amplitude (10.1 ± 3.8 % decrease, n= 6, p =
0.026; Fig. 6C) and a significant increase in locomotor burst frequency (44.1 ± 12.9 %
increase, n= 6, p = 0.010; Fig. 6D). The DHPG-induced decrease in locomotor burst
amplitude in the presence of nitric oxide signalling blockers was slightly smaller than
that recorded in the standard aCSF, whereas the increase in burst frequency was double
that recorded in the standard aCSF. These differences may again reflect greater
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variability in the output of preparations in which nitric oxide signalling is blocked.
Nevertheless, these data suggest that nitric oxide signalling is also not required for
group I mGluR-mediated modulation of rhythmic locomotor activity in mouse spinal
networks.
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Discussion
In this chapter it has been demonstrated that the activation of group I mGluRs
modulates locomotor-related network activity in isolated spinal cord preparations
obtained from neonatal mice. There were two main effects of group I mGluR
activation on pharmacologically activated rhythmic locomotor burst activity recorded
from lumbar ventral roots. One was a decrease in the amplitude of locomotor-related
ventral root activity, and the other was an increase in the frequency of rhythmic
locomotor burst activity.
The decrease in the amplitude of locomotor burst activity most likely reflects
modulation of the intensity of motoneuron firing or altered recruitment of spinal
motoneurons, which determine the final output from spinal locomotor networks.
Although modulation of the input-output relationships of motoneurons has been
demonstrated in studies concerning other intrinsic neuromodulators such as cholinergic
inputs mediated by muscarinic C-boutons on mouse spinal motoneurons (Miles et al.,
2007; Zagoraiou et al., 2009), the present study is the first to demonstrate group I
mGluR-mediated modulation of the intensity of locomotor-related motoneuron output in
mouse in vitro spinal cord preparations. It is therefore investigated, in the next chapter
(Chapter 3), what cellular mechanisms underlie group I mGluR-mediated modulation of
the input-output relationships of individual motoneurons in the mouse spinal cord.
Accompanying the decrease in locomotor burst amplitude, it has also been shown
that the activation of group I mGluRs leads to an increase in the frequency of locomotor
bursts recorded from lumbar ventral roots. A group I mGluR-mediated increase in
locomotor burst frequency is also reported in spinal locomotor networks of other
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vertebrates such as lampreys (Krieger et al., 1998) and Xenopus tadpoles (Chapman &
Sillar, 2007). In contrast, in vitro spinal cord preparations obtained from neonatal rats,
the activation of group I mGluRs via low dose agonist application slows down
locomotor burst frequency, whereas high dose agonist application completely disrupts
rhythmic burst activity (Taccola et al., 2004). Similar disruptions to rhythmic
locomotor activity were observed in mouse in vitro spinal cord preparations when
applying higher doses of the group I mGluR agonist, DHPG.
The group I mGluR-mediated modulation of locomotor burst frequency is likely to
involve modulation of spinal interneurons and synaptic transmission within locomotor
CPG networks. Depression of inhibitory synaptic transmission by the activation of
group I mGluRs is suggested in spinal locomotor networks of lampreys (Kettunen et al.,
2005; Kyriakatos & El Manira, 2007) and Xenopus tadpoles (Chapman et al., 2008).
Enhancement of excitatory transmission is also mediated by group I mGluR activation
in lamprey spinal locomotor networks (Kyriakatos & El Manira, 2007). Data from in
vitro rat spinal cord preparations show both depression and enhancement of inhibitory
synaptic transmission (Marchetti et al., 2003, 2005). Together these data support that
modulation of either excitatory and/or inhibitory synaptic transmission within
locomotor CPG networks could underlie group I mGluR-mediated modulation of
locomotor burst frequency. To fully understand the roles of group I mGluRs in the
modulation of rhythmic locomotor frequency, it will be important to directly investigate
the effects of group I mGluR activation on interneurons that make up locomotor CPGs.
However, such direct analyses of interneurons in the mammalian spinal cord are
challenging, particularly given that the neural populations which make up mammalian
spinal CPGs remain poorly defined compared to CPG networks of other evolutionary
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simpler vertebrates (Roberts, 2000; Grillner, 2006). The ongoing classification of
distinct interneuron populations, assisted by recent advances in genetic tools based on
developmental and molecular biology in the mammalian spinal cord (Jessell, 2000;
Goulding, 2009; Kiehn et al., 2010) will therefore be critical towards future studies
aiming to understand group I mGluR-mediated modulation of mammalian spinal
locomotor networks.
In addition, the present study demonstrates that the group I mGluR-mediated
modulation of spinal locomotor activity is separable into the effects mediated by the
activation of specific group I mGluR subtypes. The decrease in locomotor burst
amplitude is mediated by both mGluR1 and mGluR5 subtype activation. On the other
hand, the increase in locomotor burst frequency is mediated by mGluR1 but not
mGluR5 activation, which is also shown in lamprey locomotor networks (Kettunen et
al., 2002). The application of group I mGluR subtype specific antagonists did not
indicate endogenous activation of group I mGluRs in rhythmically active in vitro mouse
spinal cord preparations utilised in the present study. The endogenous role of group I
mGluRs is nonetheless suggested for the control of rhythmic locomotor frequency in
spinal networks of lampreys (Krieger et al., 1998; Krieger et al., 2000; Kettunen et al.,
2002), Xenopus tadpoles (Chapman & Sillar, 2007) and rats (Taccola et al., 2004). It
is possible that the inability to detect an endogenous role for group I mGluRs in
rhythmic in vitro mouse preparations may reflect compensatory activation of
serotonergic and dopaminergic receptors upon the antagonism of group I mGluRs. In
addition, the reduced nature and simple state of the in vitro preparation does not
preclude involvement of group I mGluRs in the control of locomotor networks in the
whole animal. Glutamatergic inputs to spinal locomotor CPGs that are lost or inactive
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in the in vitro preparation, such as descending inputs implicated in the initial generation
of spinal locomotor activity (Jordan et al., 2008; Hagglund et al., 2010), might activate
both ionotropic and metabotropic glutamate receptors concurrently in networks of the
vertebrate spinal cord (Delgado-Lezama et al., 1997).
In lamprey in vitro spinal cord preparations, both endocannabinoid and nitric oxide
signalling appears to be involved in the downstream effects of group I mGluR activation
(Kettunen et al., 2005; Kyriakatos & El Manira, 2007). However, the present study
has not been able to provide evidence that either endocannabioid or nitric oxide
signalling is directly involved in the group I mGluR-mediated modulation of rhythmic
locomotor activity in the in vitro mouse spinal cord preparation. Although there may
not be a direct link between group I mGluR activation and endocannabinoid or nitric
oxide signalling, this does not exclude involvement of these signalling pathways in the
modulation of mammalian spinal locomotor networks. In fact, the increased
variability in locomotor burst frequency in the presence of pharmacological blockers for
enndocannabinoid or nitric oxide signalling may suggest that these signalling pathways
are important for intrinsic modulation of mammalian spinal networks. Endogenous
modulation of spinal locomotor networks is indeed reported for enndocannabinoid
signalling in lampreys (Kettunen et al., 2005) and also for nitric oxide signalling in
Xenopus tadpoles (McLean & Sillar, 2002, 2004) and in neonatal mice (Dunford et al.,
2009).
In summary, the present study demonstrates that the activation of group I mGluRs
modulates pharmacologically induced rhythmic locomotor-related burst activity
recorded from lumbar ventral roots of in vitro spinal cord preparations obtained from
neonatal mice. The reduction in the amplitude of locomotor burst activity is likely to
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be mediated via modulation of the input-output relationships of spinal motoneurons or
modulation of synaptic transmission to motoneurons, both of which are investigated in
the next chapter (Chapter 3). The increase in locomotor burst frequency observed in
mouse in vitro spinal cord preparations is in accordance with results reported in other
vertebrates such as lampreys (Krieger et al., 1998) and Xenopus tadpoles (Chapman &
Sillar, 2007). The group I mGluR-mediated modulation of spinal locomotor networks
therefore seems evolutionally conserved from simpler vertebrate swimming networks to
mammalian walking networks, further supporting the importance of intrinsic
neuromodulation to provide animals with significant flexibility in the control of their
motor behaviour.
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Chapter 3
The role of group I mGluRs in the control of
spinal motoneuron output
Parts of the following chapter have been published in:
Iwagaki, N. and Miles, GB. (2011)
Activation of group I metabotropic glutamate receptors modulates
locomotor-related motoneuron output in mice
J Neurophysiol. 105 (5) : 2108 - 20.
- 52 -
Introduction
As discussed in the previous chapter (Chapter 2), activation of group I mGluRs
modulates locomotor-related network activity in the mouse neonatal spinal cord. The
aim of this chapter is therefore to investigate the cellular mechanisms that underlie
group I mGluR-mediated modulation of spinal locomotor activity, with particular
emphasis on modulation of the input-output relationships of spinal motoneurons that
determine the final locomotor output from spinal motor networks.
In general, group I mGluRs play an excitatory role in postsynaptic neurons by
coupling to the Gq protein which activates phospholipase C (PLC) catalysing
phosphatidylinositol 4,5-bisphosphate (PIP2) into diacyl glycerol (DAG) and inositol
triphosphate (IP3) (Anwyl, 1999, 2009). In spinal neurons including motoneurons, the
activation of group I mGluRs results in depolarisation of the resting membrane potential
in lampreys, turtles, and rats (Krieger et al., 1998; Svirskis & Hounsgaard, 1998;
Kettunen et al., 2003; Marchetti et al., 2003, 2005). The group I mGluR-mediated
depolarisation is associated with an increase in the membrane resistance of spinal
neurons in lampreys (Kettunen et al., 2003). However, data obtained from rat spinal
motoneurons suggest that the group I mGluR-mediated depolarisation is associated with
either an increase or no change in the membrane resistance (Marchetti et al., 2003,
2005). In contrast, the activation of group I mGluRs does not affect either the resting
membrane potential or the input resistance of motoneurons in the Xenopus tadpole
spinal cord (Chapman et al., 2008).
Further investigation into the cellular mechanisms of group I mGluR subtype specific
modulation reveals that activation of the mGluR1 subtype is responsible for the
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depolarisation of resting membrane potentials (Kettunen et al., 2003; Marchetti et al.,
2003), whereas mGluR5 activation induces cellular oscillations in spinal neurons of
lampreys and rats (Kettunen et al., 2002; Marchetti et al., 2003). The
mGluR1-mediated membrane depolarisation is mediated via the blockade of leak K+
currents, a process dependent on PLC, PKC and intracellular Ca2+ second messenger
signals (Kettunen et al., 2003; Nanou et al., 2009). Whereas the mGluR5-mediated
oscillation of intracellular Ca2+ requires stimulation of PLC and Ca2+ entry through
L-type but not N-type Ca2+ channels (Kettunen et al., 2002).
In addition, there have been reports of interactions between ionotropic glutamate
receptors and group I mGluRs in spinal neurons of lampreys. The activation of group
I mGluRs enhances NMDA receptor-mediated currents via PLC activation but
independent of Ca2+ released from internal stores (Krieger et al., 1998; Krieger et al.,
2000; Nanou et al., 2009). The activation of mGluR1 subtypes is also reported to
modulate AMPA-induced Na+ activated K+ currents such that a reduction of these
currents is mediated via PKC activation but an enhancement of these currents occurs
when intracellular Ca2+ is chelated (Nanou & El Manira, 2010).
Interestingly, the commonly reported excitatory effects of group I mGluR-mediated
modulation of spinal neurons, in particular motoneurons, are in contrast to the group I
mGluR-mediated reduction in the amplitude of locomotor-related burst activity
recorded from lumbar ventral roots of rhythmically active in vitro mouse spinal cord
preparations (Chapter 2). Given limited understanding of the possible mechanisms
underlying group I mGluR-mediated modulation of the intensity of the final locomotor
network output, the aim of this chapter is to elucidate roles of group I mGluRs in the
modulation of motoneuron properties and synaptic inputs to motoneurons in the
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mammalian spinal cord. This is investigated using whole-cell patch-clamp recordings
from individual motoneurons recorded in whole in vitro spinal cord preparations
obtained from neonatal mice.
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Methods
In vitro whole spinal cord preparation
Animals were dissected and spinal cords were isolated as described in the previous
chapter (Chapter 2). To perform whole-cell patch-clamp recordings from individual
motoneurons in the intact in vitro spinal cord preparation, access for patch pipettes was
created by scraping a thin line of pia matter from the ventral surface of the spinal cord
preparation, just above the motor columns at the level of the 1st or 2nd lumbar (L1 - L2)
roots (Miles et al., 2002; Fig. 7A).
Whole-cell patch-clamp recordings
Spinal motoneurons were visualised under infrared differential interference contrast
(IR-DIC) microscopy (Olympus, Tokyo, Japan). Most recorded cells were confirmed
to be motoneurons by the presence of antidromic action potentials in response to
stimulation of segmentally aligned ipsilateral ventral roots (<100 A, 0.5 ms; ISO-Flex
stimulator, A.M.P.I., Jerusalem, Israel; Fig. 7B). Patch electrodes (3 – 4 M) were
pulled on a horizontal puller (Sutter Instrument Company, Novato, CA) from
non-filamented borosilicate glass capillaries (World Precision Instruments, Sarasota,
FL). Patch-clamp signals were amplified and filtered (4 kHz low-pass Bassel filter)
with a MultiClamp 700B amplifier (Molecular Devices) and acquired at ≥10 kHz using 
a Digidata 1440A A/D board and pClamp software (Molecular Devices). Details of
voltage- and current-clamp protocols are explained in the results section. Series
resistance compensation (60 %) was used during all voltage-clamp protocols.
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Data analysis
Whole-cell patch-clamp recordings were analysed, using either Clampfit software
(Molecular Devices), Dataview software (courtesy of W. J. Heitler, University of St
Andrews) or, for mEPSC analyses, the Mini Analysis Program (Synaptosoft, Fort Lee,
NJ). Na+ current activation and inactivation curves were fitted with a Boltzmann
function in the form: 1/(1 + exp ((V1/2 – V)/k), where V1/2 is the half activation or half
inactivation voltage, V is the test or conditioning voltage, and k is the slope of the fitted
curve at V1/2. Fitting of the Boltzmann function was performed using Microsoft Excel
as described by Brown (2001). Data are reported as mean ± S.E. Differences in
means between control and drug conditions were compared using Student’s t-tests.
The Kolmogorov-Smirnov test was used to test for differences in mEPSC amplitude or
inter-event interval. Values of p < 0.05 were considered significant.
Solution and drugs
The standard aCSF solution used for dissection and recordings was identical to the
solution used in the previous chapter (Chapter 2). The standard patch-clamp pipette
solution contained 140 mM potassium methane sulfonate, 10 mM NaCl, 1 mM CaCl2,
10 mM HEPES, 1 mM EGTA, 3 mM Mg-ATP, and 0.4 mM GTP-Na2 (pH 7.2 – 7.3,
adjusted with KOH).
For experiments investigating Na+ currents in isolation, external and pipette solutions
were designed to eliminate Ca2+ and K+ currents and reduce Na+ current amplitude to
help minimise voltage-clamp errors. The modified aCSF contained 10 mM NaCl, 105
mM choline chloride, 3 mM KCl, 30 mM TEA-Cl, 10 mM HEPES, 1 mM MgCl2, 2
mM CaCl2, 10 mM D-glucose, 4 mM 4-AP, 1.5 mM kynurenic acid, 10 µM bicuculline,
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5 µM strychnine, 0.5 mM CdCl2 (gassed with 100% O2, pH 7.3 - 7.4 adjusted with
NaOH). The modified pipette solution contained 100 mM caesium methane sulfonate,
30 mM TEA-Cl, 0.5 or 10 mM NaCl, 1 mM CaCl2, 10 mM HEPES, 1 mM EGTA, 3
mM ATP-Mg, 0.4 mM GTP-Na2, (pH 7.2 – 7.3 adjusted with KOH, osmolarity adjusted
to ~290 mosmol l−1 with sucrose).
In addition to the pharmacological agents used in the previous Chapter 2, strychnine
((-)-strychnine) and bicuculline (1(S),9(R)-(−)-Bicuculline methiodide) were purchased 
from Sigma-Aldrich; TTX was purchased from Tocris Bioscience.
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Results
In the previous chapter (Chapter 2), it was shown that the activation of group I
mGluRs led to a decrease in the amplitude of locomotor-related motoneuron output
recorded from in vitro mouse spinal cord preparations. In the present chapter, the
cellular mechanisms that underlie this group I mGluR-mediated modulation of
motoneuron output was investigated using whole-cell patch-clamp recordings from
individual motoneurons in intact in vitro spinal cord preparations obtained from
neonatal mice. The effects of group I mGluR activation were assessed with bath
application of DHPG from a concentration of 10 µM to 50 µM, which maximised the
likelihood of revealing the full range of group I mGluR-mediated modulatory effects on
spinal motoneurons.
Group I mGluR-mediated effects on the sub-threshold properties of motoneurons
Firstly, the sub-threshold effects of group I mGluR activation on spinal motoneurons
were investigated. Application of DHPG significantly depolarised the resting
membrane potential of motoneurons (10 µM, 11.4 ± 1.5 mV, n = 10, p < 0.001; 50 µM,
16.0 ± 3.1 mV, n = 11, p < 0.001; Fig. 7C & 7D). The membrane potential began to
repolarise in most recorded cells during the course of the drug application (15 – 20 min)
as reported in spinal motoneurons of neonatal rats (Marchetti et al., 2003), indicating
possible desensitisation of these receptors or other components of group I mGluR
signalling pathways. To investigate the currents responsible for the DHPG-induced
depolarisation, the input resistance of motoneurons was measured using small voltage
steps (-70 to -55 mV, 2.5 mV increments, 10 ms duration) delivered in voltage-clamp
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mode (Fig. 7E). No significant change in input resistance was observed with
application of 10 µM DHPG (n = 9). However, at the higher dose of DHPG (50 µM),
a significant decrease in input resistance was revealed (52.8 ± 10.1 to 37.3 ± 3.6 M, n
= 11, p = 0.035; Fig. 7F). This reduction in input resistance was incompletely reversed
with drug washout, suggesting that group I mGluR activation may be associated with
long-term changes in conductances or that high doses of DHPG cannot be fully
removed over the time course of recordings. Current-voltage (I-V) relationships were
examined for DHPG-induced currents by subtracting I-V relationships in control from
those in the presence of DHPG (50 µM). I-V relationships obtained from individual
motoneurons were then pooled to reveal a linear I-V relationship for DHPG-induced
currents, with an approximate reversal potential of -30 mV (n = 11, Fig. 7G). These
data suggest that the activation of group I mGluRs leads to the activation or facilitation
of a mixed-cationic current in mouse spinal motoneurons.
Group I mGluR-mediated modulation of motoneuron firing properties
The group I mGluR-mediated depolarisation of motoneurons is in apparent
opposition to the decrease in locomotor-related motoneuron output recorded from
rhythmically active in vitro mouse spinal cord preparations (Chapter 2). Thus, the
effects of group I mGluR activation on the firing properties of individual motoneurons
was investigated. Repetitive firing of action potentials was evoked in motoneurons by
injection of square wave depolarising current pulses (1s duration). To study the effects
of DHPG application upon repetitive firing of motoneurons in isolation from its
depolarising effects, repolarising bias currents were applied to bring motoneuron resting
potentials back to their control levels. The application of DHPG led to a reduction in
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Figure 7: Sub-threshold effects of group I mGluR activation on individual
motoneurons recorded in an intact whole spinal cord preparation.
A) Schematic showing the experimental setup with a patch pipette targeting a spinal
motoneuron and glass suction electrodes attached to the second lumbar (L2) ventral
roots (courtesy of G. B. Miles, University of St Andrews). B) Antidromic action
potentials recorded from a motoneuron in response to stimulation of the ipsilateral
ventral root. Arrow indicates stimulus artefact. C) and D) Resting membrane
potential of motoneurons depolarised in response to DHPG application (50 M, n = 11).
E) Current recorded in response to brief sub-threshold voltage steps (10 ms, -70 to -55
mV) in a motoneuron held at -60 mV in control condition, in the presence of DHPG, and
following drug washout. F) Membrane resistance was significantly decreased by
DHPG application. G) DHPG-induced currents appeared to have a linear
current-voltage relationship, with an extrapolated reversal potential of approximately
-30 mV. * = significantly different from control.
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Figure 8: Group I mGluR-mediated effects on motoneuron firing.
Ai) Repetitive firing in a motoneuron in response to brief (1 s) square current pulses in
control condition, in the presence of DHPG (50 M), and after drug washout. Aii) The
firing frequency vs. injected current (f-I) relationship for this motoneuron was shifted to
the right by DHPG application. Aiii) The maximum firing frequency of motoneurons
was significantly reduced by DHPG application (n = 11). Bi) Traces showing the first
action potentials evoked by square current pulses in control condition, in the presence of
DHPG and after drug washout. Bii) The height and Biii) maximum rate of rise of
action potentials were significantly reduced by DHPG application (n = 9). Ci) and Cii)
The voltage threshold for action potential generation, measured by injecting a ramp of
current, was significantly hyperpolarised by DHPG application. * = significantly
different from control.
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the firing frequency of motoneurons in response to current injection (Fig. 8Ai). This
reduction in motoneuron excitability was evident as a rightward shift in the steady-state
firing frequency versus injected current (f-I) relationships of 6 out of 8 motoneurons in
response to 10 µM DHPG application and 7 out of 11 motoneurons in response to 50
µM DHPG application (Fig. 8Aii). In the remaining cells, DHPG either had no clear
effect on the f-I relationship or caused a leftward shift in the f-I relationship. Reduced
motoneuron excitability upon application of DHPG was also demonstrated by a
significant reduction in the maximum firing frequency of motoneurons (10 µM, 26.3 ±
7.6 % reduction, n = 8, p = 0.006; 50 µM, 16.1 ± 4.9 % reduction, n = 11, p = 0.031; Fig.
8Aiii). Furthermore, reduced motoneuron firing was observed in the presence of
DHPG (50 µM) even when repolarising bias currents were not injected (n = 11).
To further understand the mechanisms that underlie the group I mGluR-mediated
decrease in motoneuron excitability, parameters of action potentials were compared in
control and in the presence of DHPG. Measurements of the height and the maximum
rate of rise of the first action potential evoked by depolarising square current pulses (1s
duration) revealed a significant reduction in action potential height (10 µM, 5.5 ± 2.4
mV reduction, n = 9, p = 0.028; 50 µM, 4.2 ± 1.8 mV reduction, n = 9, p = 0.026; Fig.
8Bi & 8Bii) and a significant slowing of the maximum rate of rise (10 µM, 16.2 ± 5.0 %
reduction, n = 9, p = 0.030; 50 µM, 13.8 ± 5.9 % reduction, n = 9, p = 0.023; 8Bi &
8Biii) upon the application of DHPG. Changes in these two parameters were evident
whether the measurements were taken from the same current pulses in control and in the
presence of DHPG or from current pulses which elicited similar firing frequencies in the
two conditions.
The effect of group I mGluR activation on the voltage threshold for the generation of
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repetitive action potentials in motoneurons was also investigated. To remove the
effects of DHPG-mediated depolarisation on action potential threshold, constant
repolarising bias currents were applied. Action potentials were evoked by a ramp of
depolarising current (100 – 500 pA/s; Fig. 8Ci). The voltage threshold was defined as
the voltage at which the rate of rise of the first evoked action potential reached 10
mV/ms. Surprisingly, the voltage threshold for action potential generation was
significantly hyperpolarised during the application of DHPG (10 µM, 2.1 ± 0.7 mV
hyperpolarisation, n = 8, p = 0.008; 50 µM, 5.0 ± 1.6 mV hyperpolarisation, n = 9, p =
0.002; Fig. 8Cii). Despite hyperpolarisation of the action potential threshold, a
reduction in motoneuron firing in response to the ramp current injection was still
evident during DHPG application (Fig. 8Ci). Of note, there appears to be a reduction
in the action potential after-hyperpolarisation in the recording depicted in Fig. 8Ci.
However, this was not a consistent observation across the recordings. Finally,
hyperpolarisation of the action potential threshold was also apparent in motoneuron
recordings in response to square current pulses (Fig. 8Ai).
Taken together, the modulatory effects of group I mGluR activation upon the firing
properties of spinal motoneurons appear to be mostly inhibitory. Group I
mGluR-mediated inhibitory effects include the decreased excitability for generating
repetitive firing and the reduced height and maximum rate of rise of action potentials.
One group I mGluR-mediated excitatory effect was the hyperpolarisation of the voltage
threshold for action potential generation.
Group I mGluR-mediated modulation of Na+ currents in spinal motoneurons
Given that group I mGluR activation led to reductions in the height and maximum
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Figure 9: Group I mGluR activation modulates the fast inactivating Na+ current in
motoneurons.
A) Fast inactivating Na+ currents elicited in standard recording solutions by brief (10
ms) depolarising voltage steps in a motoneuron held at -60 mV in control condition, in
the presence of DHPG (50 M), and after drug washout. B) Plots of current-voltage
(I-V) relationships and C) average peak current density for fast inactivating Na+ currents
demonstrate a DHPG-mediated reduction in the density of Na+ currents (n = 11). D)
Na+ currents recorded in modified solutions (TEA, 4-AP, Cs+, CdCl2, bicuculline,
strychnine, and kynurenic acid) designed to block Ca2+ channels, K+ channels, and
synaptic transmission and to reduce Na+ current magnitude by lowering the
concentration of extracellular Na+ (10 mM). E) Plots of I-V relationships and F)
average peak current density for Na+ currents again demonstrate a DHPG (50
M)-mediated reduction in Na+ current density (n = 6). G) Normalised activation and
H) steady-state inactivation curves plotted in control condition and in the presence of
DHPG demonstrate no change in the voltage dependence of activation or steady-state
inactivation of Na+ currents. * = significantly different from control.
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rate of rise of action potentials in motoneurons, it can be hypothesised that group I
mGluR activation modulates Na+ channels that mediate the fast, inactivating Na+
current. This was tested by eliciting Na+ currents in motoneurons in voltage-clamp
mode, using a series of small voltage steps (-70 to +20 mV, 2.5 mV increments, 10 ms
duration) from a holding potential of -60 mV in control conditions and in the presence
of DHPG (Fig. 9A). Analyses of Na+ currents were performed on leak subtracted
traces. In standard recording aCSF and pipette solutions, the density of fast,
inactivating Na+ currents was significantly reduced during the application of DHPG
(Fig. 9B & 9C). The peak current density, elicited by steps to -27.5 mV, was
significantly reduced by 19.4 ± 8.4 % in response to 10 µM DHPG (n = 9, p = 0.018)
and by 18.7 ± 5.3 % in response to 50 µM DHPG (n = 11, p < 0.001; Fig. 9B & 9C).
The occurrence of voltage- and space-clamp errors is increased when recording large
currents from large neurons. Although these errors are likely to be equivalent in
control and in the presence of DHPG, it is also possible that changes in cell properties
induced by DHPG may differentially affect the ability to control voltage in the two
conditions. It was therefore assessed whether DHPG application also modulated Na+
currents when other channel types (Ca2+ and K+) and synaptic transmission were
pharmacologically blocked. In addition, modified recording solution with lowered
extracellular Na+ concentration (10 mM NaCl) was utilised to reduce the amplitude of
Na+ currents (Carlier et al., 2006). In these modified pipette and recording solutions
Na+ currents, elicited by depolarising steps (-70 to +20 mV, 2.5 mV increments, 10 ms
duration) from a holding potential of -60 mV, were more than 10-fold smaller than those
recorded in standard solutions (Fig. 9D). With Na+ currents considerably reduced and
other channels and synaptic transmission blocked, the application of DHPG (50 µM)
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still led to a significant decrease in the peak density of Na+ currents (20.3 ± 7.8 %
reduction, n = 6, p = 0.017; Fig. 9E & 9F).
To investigate the mechanisms by which group I mGluR activation modulates Na+
currents, the voltage dependence of Na+ current activation and inactivation was
analysed in control and in the presence of DHPG (50 µM) using the modified
intracellular and recording solutions. Activation of Na+ currents was investigated
using depolarising steps from a holding potential of -60 mV (-70 to +20 mV, 2.5 mV
increments, 10 ms duration; Fig. 9G). Steady-state inactivation of Na+ currents was
investigated using steps to 0 mV (10 ms duration) from pre-pulses (50 ms duration)
ranging from -90 to -5 mV (5 mV increments; Fig. 9H). There were no significant
changes in the half-maximal activation voltage of Na+ currents in the presence of DHPG
(-31.4 ± 1.1 mV in control, -33.2 ± 1.7 mV in DHPG, n = 6; Fig. 9G). The half
maximal voltage of steady-state inactivation was also unchanged by DHPG application
(-51.0 ± 0.8 mV in control, -51.1 ± 0.9 mV in DHPG, n = 6; Fig. 9H). These data
indicate that the activation of group I mGluRs modulates Na+ current density by means
other than affecting the voltage dependence of activation or inactivation of Na+ currents.
Group I mGluR subtype specific effects on intrinsic properties of motoneurons
The results thus far have demonstrated that the activation of group I mGluRs
modulates a wide range of intrinsic properties of motoneurons in the spinal cord of
neonatal mice. Although the effects of group I mGluR activation include
depolarisation of the resting membrane potential and hyperpolarisation of the voltage
threshold for repetitive action potential generation, the most pronounced effect is a
reduction in motoneuron excitability, which is likely due to the modulation of Na+
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Figure 10: Receptor subtype-specific effects of group I mGluR activation on
sub-threshold properties of motoneurons.
Ai, Aii and Aiii) A DHPG (10 M)-meditated depolarisation of resting membrane
potentials was blocked by the mGluR1 antagonist LY367385 (50 M, n = 8) but not by
the mGluR5 antagonist MPEP (10 M, n = 9). Bi) and Bii) Membrane resistance,
calculated from sub-threshold voltage steps (150 ms, -70 to -50 mV) in a motoneuron
hold at -60 mV, was significantly reduced by DHPG application even in the presence of
LY367385. Ci) and Cii) DHPG-mediated reduction in membrane resistance was
blocked by MPEP. D) Small DHPG-induced currents, with an extrapolated reversal
potential of approximately -15 mV were detected in the presence of LY367385. Larger
DHPG-induced depolarising currents in the presence of MPEP show horizontal I-V
relationships. * = significantly different from control.
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channels. As was shown in the previous chapter (Chapter 2), the group I
mGluR-mediated modulation of the intensity of locomotor-related motoneuron output
involves activation of both mGluR1 and mGluR5 subtypes. Therefore, the next aim
was to identify which receptor subtypes are responsible for the various effects of group I
mGluR-mediated modulation of mouse spinal motoneurons. Replicating the
whole-cell patch-clamp recording protocols described above, the effects of DHPG (10
M) application in the presence of either mGluR1 (LY367385, 50 M) or mGluR5
(MPEP, 10 M) specific antagonists were investigated.
The sub-threshold effects mediated by the activation of group I mGluR subtypes in
spinal motoneurons were first analysed. The membrane depolarisation normally
induced by DHPG application was blocked by LY367385 (n = 8; Fig. 10Ai & 10Aii).
In comparison, the application of DHPG was still associated with a significant
membrane depolarisation in the presence of MPEP (9.4 ± 2.0 mV depolarisation, n = 9,
p < 0.001; Fig. 10Ai & 10Aiii). Input resistance was measured, using small voltage
steps (-70 to -50 mV, 2.5 mV increments, 150 ms duration) from a holding potential of
-60 mV (Fig. 10Bi & 10Ci). Although the depolarising effect of DHPG application
was blocked by LY367385, the input resistance was still significantly decreased with
DHPG application (44.4 ± 4.3 Mto39.7 ± 3.4 Mn = 8, p = 0.025; Fig. 10Bi &
10Bii). On the other hand, despite the membrane depolarisation recorded, the input
resistance was unchanged by DHPG application in the presence of MPEP (n = 9; Fig.
10Ci & 10Cii). Analyses of the I-V relationships for DHPG-induced currents revealed
small currents that would reverse at approximately -15 mV during DHPG application in
the presence of LY367385 (n = 8; Fig. 10D). The absence of a significant membrane
depolarisation in motoneurons from DHPG-induced small currents makes interpretation
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difficult. However, one explanation is that the decreased input resistance shunted the
mGluR1-mediated small currents therefore limiting changes in voltage across the cell
membrane. In contrast, DHPG application in the presence of MPEP led to large
depolarising inward currents that demonstrated horizontal I-V relationships (n = 9; Fig.
10D).
The receptor subtypes responsible for the group I mGluR-mediated reduction in the
excitability of spinal motoneurons were examined next. Almost all of the modulatory
effects upon motoneuron firing normally induced by DHPG application were no longer
evident in the presence of the mGluR1 specific antagonist, LY367385. DHPG
application had no consistent effect on the steady-state f-I relationships of motoneurons
in the presence of LY367385 (n = 8; Fig. 11Ai), with maximum firing frequencies
unchanged (n = 8; Fig. 11Aii). The height and maximum rate of rise of the first action
potential evoked by square current pulse injection (1 s duration) also remained
unchanged when DHPG was applied in the presence of LY367385 (n = 7; Fig. 11B).
However, analysis of the voltage threshold for action potential generation in response to
a ramp of current injection (3 s duration) revealed that the hyperpolarisation of action
potential threshold was still induced by DHPG application even in the presence of
LY367385 (Fig. 11Ci & 11Cii). The threshold for action potential generation
significantly hyperpolarised by 3.5 ± 0.9 mV in response to DHPG application in the
presence of LY367385 (n = 7, p = 0.004; Fig. 11Cii).
In keeping with the above experiments utilising the mGluR1 antagonist, LY367385,
most of the DHPG-induced modulatory effects on motoneuron excitability were
preserved in the presence of the mGluR5 antagonist, MPEP. Although obvious
rightward shifts in steady-state f-I relationships in response to DHPG application (Fig.
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Figure 11: Effects of group I mGluR activation on motoneuron firing in the
presence of LY367385.
Ai) No consistent effect of DHPG application (10 M) on steady state firing frequency
vs. injected current (f-I) relationships was observed in motoneurons in the presence of
LY367385 (50 M). Aii) LY367385 blocked the DHPG-mediated decrease in
maximum firing frequency of motoneurons (n = 8). Bi) Traces showing the first action
potentials evoked by square current pulses (1 s) in control condition, during DHPG
application and after drug washout in the presence of LY367385. Bii) The height and
Biii) maximum rate of rise of these action potentials remained unchanged by DHPG
application in the presence of LY367385 (n = 7). Ci) and Cii) The voltage threshold
for action potential generation, measured by injecting a current ramp, was still
significantly hyperpolarised by DHPG application in the presence of LY367385. * =
significantly different from control.
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Figure 12: Effects of group I mGluR activation on motoneuron firing in the
presence of MPEP.
Ai) Steady state f-I relationships recorded in a motoneuron in the presence of MPEP (10
M). Aii) MPEP did not block the DHPG (10 M)-induced decrease in maximum
firing frequency of motoneurons (n = 9). Bi) Traces showing the first action potentials
evoked by square current pulses (1 s) in control condition, during DHPG application
and drug washout in the presence of MPEP. Bii) The height and Biii) maximum rate
of rise of these action potentials were still significantly reduced by DHPG application in
the presence of MPEP. Ci) and Cii) MPEP, however, blocked the DHPG-mediated
hyperpolarisation of voltage thresholds for action potential generation. * =
significantly different from control.
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12Ai) were not often evident in motoneurons recorded in the presence of MPEP (2 out
of 9 motoneurons), the maximum firing frequency of motoneurons was significantly
reduced by DHPG application in the presence of MPEP (21.7 ± 9.5 % reduction, n = 9,
p = 0.031; Fig. 12Aii). In addition, the height and maximum rate of rise of the first
action potential evoked by square current pulse injection (1 s duration) were both
significantly reduced when DHPG was applied in the presence of MPEP (5.4 ± 1.4 mV
height reduction, n = 9, p = 0.002; 18.2 ± 3.4 % max. rise reduction, n = 9, p = 0.002;
Fig. 12B). Again, as predicted from data obtained in the presence of LY367385,
MPEP did block the hyperpolarising effect of DHPG application upon the voltage
threshold for action potential generation, resulting in unchanged voltage thresholds for
action potentials evoked by injections of ramp currents in control and during DHPG
application (n = 9; Fig. 12Ci & Cii).
Consistent with a dominant role of the mGluR1 subtype in the group I
mGluR-mediated reduction in motoneuron excitability, the modulation of fast
inactivating Na+ currents also appeared to be primarily mediated via the activation of
the mGluR1 subtype. LY367385 blocked DHPG-induced reductions in the density of
fast inactivating Na+ currents (Fig. 13Ai), leaving the peak Na+ current density
unchanged with DHPG application (n = 8; Fig. 13Aii). In contrast, MPEP did not
block the effect of DHPG application upon fast inactivating Na+ currents (Fig. 13Bi).
A significant reduction in the peak Na+ current density was observed when DHPG was
applied in the presence of MPEP (18.1 ± 2.5 % reduction, n = 9, p < 0.001; Fig. 13Bii).
Taken together these detailed analyses of the involvement of group I mGluR
subtypes in the modulation of the intrinsic properties of spinal motoneurons indicate
that the majority of the modulatory effects observed are mediated by the activation of
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Figure 13: Receptor subtype-specific effects of group I mGluR activation 
upon modulation of fast inactivating Na+ currents.  
Ai) Plots of current-voltage (I-V) relationships and Aii) average peak current 
density for fast inactivating Na+ currents demonstrate that LY367385 (50 µM) 
blocked the DHPG-mediated reduction in the density of Na+ currents (n = 8).  Bi) 
Plots of I-V relationships and Bii) average peak current density for fast inactivating 
Na+ currents demonstrate that DHPG application still significantly reduced the 
density of Na+ currents in the presence of MPEP (10 µM, n = 9).  
* significantly different from control.
*
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mGluR1 subtypes. However, the activation of mGluR5 subtypes appears to mediate
one of the few potential excitatory effects of group I mGluR activation, the
hyperpolarisation of the voltage threshold for action potential generation.
Group I mGluR-mediated modulation of synaptic transmission to motoneurons
The present study has shown that several intrinsic properties of motoneurons are
modulated by the activation of group I mGluRs. Further, to elucidate the synaptic
mechanisms underlying the group I mGluR-mediated modulation of locomotor-related
motoneuron output, it was also investigated whether the activation of group I mGluRs
could alter excitatory synaptic inputs to spinal motoneurons. Rhythmic
locomotor-related synaptic drive originating from pre-motor CPG interneurons was
recorded from motoneurons held at -60 mV in pharmacologically activated (5 µM
NMDA; 10 µM 5-HT; 50 µM dopamine) in vitro spinal cord preparations (Fig. 14A).
The rhythmic synaptic drive received by motoneurons was in phase with bursts of
locomotor activity recorded from segmentally aligned ventral roots. When DHPG (10
µM) was bath applied, the amplitude of rhythmic locomotor drive was significantly
reduced by 10.4 ± 7.6 % (n = 10, p = 0.035; Fig. 14A & 14B). Thus, the activation of
group I mGluRs indeed modulates locomotor-related excitatory synaptic transmission to
motoneurons. The reduction in the intensity of locomotor-related motoneuron output
observed upon the activation of group I mGluRs (Chapter 2) is therefore likely to reflect
not only modulation of the intrinsic properties of motoneurons but also modulation of
the excitatory locomotor-related synaptic drive that motoneurons receive from
pre-motor CPG interneurons.
Next it was investigated whether the group I mGluR-mediated modulation of
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excitatory synaptic transmission to motoneurons involves pre- or postsynaptic
mechanisms. Miniature excitatory postsynaptic currents (mEPSCs) were recorded in
voltage-clamp mode while motoneurons were held at -60 mV (Fig. 14C). To isolate
mEPSCs, TTX (0.5 µM), strychnine (5 µM) and bicuculline (10 µM) were added to the
recording aCSF. Upon the application of DHPG (50 µM), both the amplitude and
frequency of mEPSCs were reduced (Fig. 14C, 14D & 14E). DHPG-mediated
decreases in mEPSC amplitude and frequency were evident as leftward shifts in
cumulative frequency plots generated from data collected from individual motoneurons
(Fig. 14Di & 14Dii). As revealed using the Kolmogorov-Smirnov test, DHPG
application led to a significant reduction in mEPSC amplitude in 7 out of 13
motoneurons and a significant decrease in mEPSC frequency in 8 out of 13
motoneurons. In addition, average mEPSC amplitude across all motoneurons
decreased significantly from 20.0 ± 0.8 to 19.2 ± 0.8 pA (n = 13, Student’s t-test p =
0.023; Fig. 14Ei), while average mEPSC frequency decreased significantly from 6.2 ±
0.8 to 4.9 ± 0.7 Hz (n = 13, Student’s t-test p = 0.004; Fig. 14Eii). Together these
results indicate that the activation of group I mGluRs reduces excitatory synaptic
transmission to motoneurons via both pre- and postsynaptic mechanisms.
- 82 -
Figure 14: Effects of group I mGluR activation on synaptic input to motoneurons.
A) Rhythmic locomotor-related drive currents recorded from a motoneuron held at -60
mV in control condition, in the presence of DHPG (10 M), and after drug washout.
B) The amplitude of locomotor drive was significantly decreased by DHPG application
(n = 10). C) Miniature excitatory postsynaptic currents (mEPSCs) recorded from a
motoneuron in the presence of tetrodotoxin (TTX, 0.5 M), bicuculline (10 M), and
strychnine (5 M). Di) Cumulative probability plots showing a significant decrease in
mEPSC amplitude and Dii) frequency, following DHPG application (50 M). Ei)
Pooled data demonstrating that DHPG caused a significant decrease in both mEPSC
amplitude and Eii) frequency (n = 13). * significantly different from control.
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Discussion
The present study has demonstrated that the activation of group I mGluRs modulates
a wide range of cellular properties that determine the firing output generated by spinal
motoneurons. Targets of group I mGluR-mediated modulation include both the
intrinsic properties of motoneurons and the synaptic input that motoneurons receive
from pre-motor CPG interneurons. Despite revealing both excitatory and inhibitory
effects of group I mGluR activation on spinal motoneurons, the net modulatory effect of
group I mGluR activation is to reduce both the excitability of motoneurons and
excitatory synaptic transmission received by motoneurons. The net inhibitory role of
group I mGluRs on spinal motoneurons is therefore likely to underlie the reduction in
the amplitude of locomotor-related output recorded from lumbar ventral roots of
rhythmically active in vitro mouse spinal cord preparations (Chapter 2).
One of the presumptive group I mGluR-mediated excitatory effects in motoneurons,
which may appear in opposition to the group I mGluR-mediated reduction in
motoneuron excitability, was depolarisation of the resting membrane potential of spinal
motoneurons following the activation of group I mGluRs. Group I mGluR-mediated
depolarisation of the resting membrane potential is commonly reported in spinal
motoneurons of lampreys (Krieger et al., 1998; Kettunen et al., 2003), turtles (Svirskis
& Hounsgaard, 1998), and rats (Marchetti et al., 2003, 2005), as well as
respiratory-related brainstem motoneurons of rats (Del Negro & Chandler, 1998; Dong
& Feldman, 1999). In contrast, the activation of group I mGluRs did not lead to
membrane depolarisation in spinal motoneurons of Xenopus tadpoles (Chapman et al.,
2008). Data from the present study have shown that the membrane depolarisation is
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likely mediated via the activation of mGluR1, but not mGluR5 subtypes, which is in
accordance with reports in lamprey and rat in vitro spinal cord preparations (Kettunen et
al., 2003; Marchetti et al., 2003). However, the ionic mechansims that underlie the
group I mGluR-mediated membrane depolarisation appear to be different in the present
study of mouse spinal motoneurons compared to studies of motoneurons in other
species. The group I mGluR-mediated membrane depolarisation of motoneurons is
most often associated with an increase in membrane input resistance likely reflecting the
blockade of leak K+ currents (Del Negro & Chandler, 1998; Svirskis & Hounsgaard,
1998; Dong & Feldman, 1999; Kettunen et al., 2003; Marchetti et al., 2005). However,
the present study found that group I mGluR-mediated depolarisation was associated
with a decrease in input membrane resistance, with the underling current reversing at
approximately at -30 mV. These data suggest that the activation of group I mGluRs in
mouse spinal motoneurons involves the opening of non-selective cationic channels, as
has been reported previously in other neuronal types within the mammalian brain
(Congar et al., 1997; Dong et al., 2009; Kolaj & Renaud, 2010). Other currents that
cannot be ruled out as underlying group I mGluR-mediated modulation include currents
mediated by Na+-Ca2+ exchangers (Keele et al., 1997; Lee & Boden, 1997; Jian et al.,
2010) and Na+-K+-2Cl- co-transporters (Schomberg et al., 2001).
The analyses of the involvement of group I mGluR specific subtypes in the
membrane depolarisation and the decrease in membrane resistance in spinal
motoneurons suggest a possible separation in signalling mechanisms responsible for
these two modulatory effects. The depolarisation of the membrane potential depends
on the activation of mGluR1 subtypes, while the decrease in membrane resistance
appears to require the activation of mGluR5 subtypes. Interestingly, studies in rat
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spinal motoneurons have reported that group I mGluR-mediated membrane
depolarisations are associated with either an increase or no change in membrane
resistance (Marchetti et al., 2003, 2005). Additionally, in rat spinal motoneurons, the
membrane depolarisation appears to be mediated by the activation of mGluR1 subtypes
while oscillations in membrane potential are induced by the activation mGluR5
subtypes (Marchetti et al., 2003). Also oscillation of intracellular Ca2+ concentrations
is reported in spinal neurons of lampreys, mediated via the activation of mGluR5
subtypes and Ca2+ influx from L-type but not N-type Ca2+ channels (Kettunen et al.,
2002). It therefore seems that further work is needed to clarify which ion channels
underlie the group I mGluR-mediated membrane depolarisation and to determine the
sub-threshold effects of specific group I mGluR subtypes in mammalian spinal
motoneurons.
Although the group I mGluR-mediated membrane depolarisation would suggest an
increase in the excitability of spinal motoneurons, results from the previous chapter
have demonstrated a reduction in the intensity of locomotor-related motoneuron output
in response to the activation of group I mGluRs (Chapter 2). The group I
mGluR-mediated membrane depolarisation might suggest a depolarising block of action
potentials, nevertheless this was unlikely based on the magnitude of the depolarisation
induced by group I mGluR activation. Furthermore, the time course of the group I
mGluR-mediated depolarisation differed from that of the reduction in the amplitude of
locomotor-related motoneuron output. Instead, the net inhibitory effect of group I
mGluR activation on spinal motoneurons appears to involve the modulation of the
ability of spinal motoneurons to produce repetitive firing of action potentials.
The present study has demonstrated that the frequency of repetitive action potential
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firing decreases upon the activation of group I mGluRs in mouse motoneurons. This is
in contrast to other detailed studies of the effects of group I mGluR activation on the
firing of individual vertebrate motoneurons, performed in turtles, which demonstrated
that the activation of group I mGluRs enhances sustained firing or plateau potentials via
the facilitation of voltage-activated Ca2+ channels (Delgado-Lezama et al., 1997;
Svirskis & Hounsgaard, 1998). In addition to demonstrating a group I
mGluR-mediated decrease in repetitive firing in mouse motoneurons, the present study
demonstrated mGluR-mediated reductions in action potential height and maximum rate
of rise that are consistent with reduced Na+ channel availability (Miles et al., 2005). In
support of this, voltage-clamp analysis of fast, inactivating Na+ currents suggests a
reduction in Na+ current density upon activation of group I mGluRs. Although the
conclusions from data concerning the effects of group I mGluR activation upon Na+
current density may be complicated by voltage- and space-clamp errors, the
experimental design was modified to reduce the likelihood of these errors through the
use of modified recording solutions. Using this methodology, other channels types (K+
and Ca2+) and synaptic transmission were blocked, while the magnitude of Na+ currents
was also reduced (Cantrell et al., 1997; Carr et al., 2003; Miles et al., 2005; Carlier et
al., 2006). In addition, analyses of the involvement of specific group I mGluR
subtypes on these inhibitory effects in mouse spinal motoneurons revealed that all of
these modulatory effects are mediated via the activation of mGluR1 but not mGluR5
subtypes. Data presented in this chapter thus indicate that the mGluR1-mediated
modulation of Na+ channel properties and the subsequent inhibition of motoneuron
firing are likely to contribute to group I mGluR-mediated reductions in the intensity of
locomotor-related motoneuron output recorded from rhythmically active in vitro spinal
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cord preparations of neonatal mice (Chapter 2).
Although this is the first report that the activation of group I mGluRs modulates Na+
channels and the shape of action potentials in mouse spinal motoneurons, similar
findings have been reported in cortical pyramidal neurons (Carlier et al., 2006). In
these neurons, group I mGluR activation hyperpolarises the inactivation of transient Na+
currents, which results in a decrease in Na+ current amplitude. The decreased Na+
current amplitude underlies reductions in action potential height and maximum rate of
rise and ultimately lowers the frequency of repetitive action potential firing (Carlier et
al., 2006). In contrast, the present study has shown in mouse spinal motoneurons that
the activation of group I mGluRs reduces Na+ current density without changing the
voltage dependence of steady-state inactivation. Data from the present study are,
however, similar to previous reports in hippocampal neurons where phosphorylation of
Na+ channels, following activation of either dopaminergic or muscarinic receptors,
decreases peak Na+ current without affecting the voltage dependence of activation or
steady-state inactivation (Cantrell et al., 1996; Cantrell et al., 1997). In such cases,
reduced Na+ channel availability may instead reflect modulation of slow inactivation
(Carr et al., 2003), altered rates of inactivation, or a decrease in the unitary conductance
of single channels.
The present study has also demonstrated that the activation of group I mGluRs
hyperpolarises voltage thresholds for repetitive action potential generation in mouse
spinal motoneurons Unlike the mGluR1-mediated inhibitory effects on the firing of
spinal motoneurons, the hyperpolarisation of the action potential threshold was found to
be mGluR5-mediated. Interestingly, it has recently been shown that an undefined
intra-spinal system hyperpolarises the voltage threshold for action potentials during
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fictive scratch in cats (Power et al., 2010). In the rat spinal cord, protein kinase C, a
downstream target of group I mGluRs (Pin & Duvoisin, 1995) is shown to modulate the
voltage threshold for spike initiation (Dai et al., 2009). Therefore it seems plausible
that group I mGluRs form part of the intra-spinal system suggested in the cat (Power et
al., 2010) to control action potential threshold in a state-dependent manner. Although
the mechanisms underlying group I mGluR-mediated modulation of action potential
threshold remain unclear, the present data do not support a role for the modulation of
the activation properties of fast inactivating Na+ currents. Other potential mechanisms
include the modulation of persistent Na+ currents (Carlier et al., 2006) and delayed
rectifier K+ channels (Dai et al., 2009).
In addition to the modulation of intrinsic properties of motoneurons, it is
demonstrated that the activation of group I mGluRs reduces excitatory synaptic
transmission to spinal motoneurons. Group I mGluR-mediated modulation of
excitatory and/or inhibitory synaptic transmission has been reported in spinal networks
of lampreys, Xenopus tadpoles and rats (Marchetti et al., 2003; Kettunen et al., 2005;
Marchetti et al., 2005; Kyriakatos & El Manira, 2007; Chapman et al., 2008). The
present study concentrated on the effect of group I mGluR activation on excitatory
synaptic transmission since the modulation of rhythmic excitatory locomotor drive to
motoneurons seemed most likely to underlie the decrease in locomotor-related
motoneuron output recorded in rhythmically active in vitro spinal cord preparations. It
could be argued that modulation of inhibition, should it occur concurrent with rhythmic
excitation (Berg et al., 2007) or should it contribute to the circuitry of recurrent
inhibition, could also be responsible for the group I mGluR-mediated decrease in the
amplitude of locomotor-related synaptic drive to motoneurons. This possibility cannot
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be ruled out, but it seems unlikely given that concurrent inhibition and excitation of
motoneurons does not appear to be a feature of locomotion in mice (Endo & Kiehn,
2008). In addition, a previous study using rat in vitro spinal cord preparations reported
that the activation of group I mGluRs depressed recurrent inhibition to spinal
motoneurons (Marchetti et al., 2005).
Findings from the present study indicate that group I mGluR-mediated modulation of
excitatory synaptic drive to motoneurons involves both pre- and postsynaptic
mechanisms. Although the exact mechanisms need to be investigated further, one
possible pre-synaptic mechanism, based on the present findings, could be group I
mGluR-mediated inhibition of transient Na+ currents in pre-synaptic terminals. Other
potential mechanisms include those revealed in lamprey in vitro spinal cord preparations
where modulation of both excitatory and inhibitory transmission involves retrograde
signalling of endocannabinoids and volume transmission of nitric oxide (Kettunen et al.,
2005; Kyriakatos & El Manira, 2007; Kyriakatos et al., 2009). However, findings in
the previous chapter (Chapter 2), suggesting that the modulatory effects of group I
mGluR activation on spinal locomotor activity are independent of endocannabinoid and
nitric oxide signalling, put this hypothesis unlikely. Modulatory interactions of group I
mGluRs and iGluRs, such that group I mGluR activation modulates both NMDA and
AMPA receptor-mediated currents (Krieger et al., 1998; Krieger et al., 2000; Nanou et
al., 2009; Nanou & El Manira, 2010), provide potential mechanisms for postsynaptic
modulation.
Taken together, data from the present study and previous research demonstrate that
the actions of group I mGluRs on motoneurons are complicated by the existence of
multiple effects including the modulation of intrinsic neuronal properties and synaptic
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transmission. This may allow considerable flexibility in the actions of group I
mGluRs when the multiple effects they mediate are controlled by pathways that are
separable, for example, based on the group I mGluR subtype activated (mGluR1 vs.
mGluR5) or the second messenger signalling involved. In support of this, in the
present study, it has been demonstrated that modulatory effects culminating in decreased
motoneuron excitability are mediated via mGluR1 subtypes whereas modulatory effects
which are likely to increase motoneuron excitability, specifically a hyperpolarisation of
the voltage threshold for action potential generation, is mediated by the activation of
mGluR5 subtypes. Further support for the functional division of group I
mGluR-mediated signalling is provided in the lamprey spinal cord where separable
intracellular signalling pathways downstream of mGluR1 activation are reported, such
as PLC-mediated potentiation of NMDA currents and PKC-dependent blockade of leak
channels (Nanou et al., 2009). Interestingly, in opposition to the independence of
separate aspects of group I mGluR-mediated signalling, studies of striatal cholinergic
neurons have demonstrated an interaction between subtypes of group I mGluRs with
mGluR5 modulating mGluR1 activity (Bonsi et al., 2005).
In brainstem motoneurons, where group I mGluR activation also depresses excitatory
inputs and mediates membrane depolarisation, group I mGluRs have been suggested to
play a role in sculpting the final output of motoneurons by favouring strong synaptic
inputs and amplifying their effects (Del Negro & Chandler, 1998). Findings from the
present study suggest that group I mGluR activation might mediate similar enhancement
of the signal-to-noise ratio of synaptic inputs to spinal motoneurons by reducing
excitatory inputs but depolarising the resting membrane potential and hyperpolarising
the action potential threshold. However, the inhibition of repetitive firing via the
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modulation of Na+ channels may be inconsistent with this. Alternatively, modulation
of Na+ currents and repetitive firing may represent a separate role for group I mGluRs in
limiting the output of spinal motoneurons, perhaps in the presence of intense
glutamatergic input, to provide homeostatic control of motoneuron output (Desai, 2003;
Carlier et al., 2006).
Evidence that a single neuromodulator provides neural networks with opposing
neuromodulatory effects to limit the overall network output have been discussed in
spinal locomotor CPG networks (Harris-Warrick, 2011). If glutamate provides spinal
locomotor networks with such homeostatic control mediated via the activation of group
I mGluRs, this might also serve to protect spinal networks from intensive glutamatergic
stimulation such as glutamatergic excitotoxicity. Data support a neuroprotective role
for group I mGluRs in pathological conditions affecting spinal motor networks such as
amyotrophic lateral sclerosis (ALS; Anneser et al., 1999; Anneser et al., 2004; Ma et al.,
2006) where glutamate-mediated excitotoxicity is thought to contribute to motoneuron
death (Boillee et al., 2006). Further analyses of the role of mGluRs in motoneurons
may therefore be of importance, not only for understanding the control of motor outflow
from the CNS, but also toward the design of new treatments for degenerative diseases
that afflict spinal motor systems. Therefore the focus of the next chapter will be to
investigate whether group I mGluRs play any role in the pathology of the
neurodegenerative disease, ALS.
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Chapter 4
The role of group I mGluRs in the early
pathogenesis of Amyotrophic Lateral Sclerosis
- 94 -
Introduction
The present study has so far discussed a wide variety of roles that group I mGluRs
play in the modulation of locomotor networks of the mammalian spinal cord. This
final chapter moves on to investigate whether these group I mGluR-mediated
modulatory effects are perturbed in spinal locomotor networks under pathological
conditions. One devastating disease that affects motor functions of the spinal cord is
amyotrophic lateral sclerosis (ALS). In patients affected by ALS, motoneurons are
selectively lost by unknown causes, leading to the loss of somatic motor control and
subsequently the fatal paralysis of respiratory muscles 2 – 3 years after disease onset.
90 % of ALS cases are sporadic, but the remaining 10 % are attributable to familial
(genetic) causes. 20 % of familial cases of ALS are known to be caused by specific
mutations in the gene encoding the enzyme superoxide dismutase-1 (SOD-1).
Genetically engineered transgenic mice that express the mutant SOD-1 gene have been
widely used as experimental model animals of ALS, since the pathological phenotype
exhibited by mutant SOD-1 transgenic mice resembles the disease progression of
human ALS patients (Julien & Kriz, 2006). Several hypotheses are currently proposed
to explain the pathogenesis of ALS, which include mitochondrial dysfunction, cellular
oxidative stress, disorganisation of neurofilaments, toxic intracellular aggregates, and
glutamatergic excitotoxicity (Bruijn et al., 2004; Boillee et al., 2006). However, it is
highly likely that ALS is a multi-factorial disease with several pathological mechanisms
converging to cause the final death of motoneurons.
Although ALS is a multi-factorial disease, the hypothesis that glutamatergic
excitotoxicity is involved in the pathogenesis of ALS seems to have received the most
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support. Firstly, a raised concentration of glutamate in cerebrospinal fluid is reported
in 40 % of ALS patients (Spreux-Varoquaux et al., 2002). Secondly, the astroglial
glutamate transporter, excitatory amino acid transporter 2 (EAAT2), which is
responsible for removal of glutamate from extracellular spaces, is reported as having
reduced expression in ALS patients (Rothstein et al., 1995; Fray et al., 1998) and also in
ALS model mice (Bruijn et al., 1997). Finally, riluzole, the only drug clinically
approved to date for the treatment of ALS, is thought to inhibit glutamate release (Doble,
1996). Thus, evidence points strongly towards glutamatergic excitotoxicity, initiated
not only by an excessive release of glutamate into synaptic clefts but also by abnormal
removal of glutamate from extracellular spaces, as playing a key role in the pathology
of ALS.
The involvement of glutamatergic excitotoxicity in the pathogenesis of ALS is often
discussed in the context of iGluR-mediated Ca2+ influx, in particular mediated via Ca2+
permeable AMPA receptors, which leads to a disturbance in intracellular Ca2+
homeostasis (Arundine & Tymianski, 2003; Van Den Bosch et al., 2006). However,
the role of group I mGluRs in glutamatergic excitotoxicity in ALS has received
considerably less research attention, despite the fact that the activation of group I
mGluRs is positively coupled to mechanisms that increase intracellular Ca2+
concentration (Anwyl, 1999, 2009). There are limited data available that indicate a
possible role of group I mGluRs in ALS, although these data may support complex and
dual neuroprotective and neurotoxic effects of group I mGluRs in the pathology of ALS.
In human ALS patients, higher levels of group I mGluR expression are reported,
particularly on glial cells in the spinal cord (Aronica et al., 2001). Analyses of
expression of group I mGluR subtypes in motoneuron populations of the brainstem and
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the spinal cord demonstrate higher levels of mGluR1 expression, but lower levels of
mGluR5 expression, in ALS-vulnerable motoneuron populations, such as the VII and
XII brainstem motor nuclei and spinal motoneurons, compared to ALS-resistant
motoneuron populations such as the III, IV and VI brainstem motor nuclei in both
humans and rats (Laslo et al., 2001; Ma et al., 2006). Unlike most spinal motoneurons,
lumbosacrally-located parasympathetic motoneurons of Onuf’s nucleus, which are
known to be resistant to neurodegeneration in ALS, show higher levels of mGluR5
expression, while levels of mGluR1 expression do not differ between Onuf’s nucleus
and the somatic spinal motoneuron population (Anneser et al., 2004). Therefore it
seems that high levels of mGluR1 expression may facilitate neuronal degeneration
while mGluR5 expression may protect neurons from degeneration in ALS. Such a
dual role of group I mGluRs may reflect mixed evidence that group I mGluRs promote
or inhibit glutamate-induced death of motoneurons depending on experimental
conditions. Application of group I mGluR agonists prevents kainate-induced neuronal
death in spinal cord slices obtained from adult rats (Pizzi et al., 2000; Valerio et al.,
2002). However, application of either an agonist or an antagonist of group I mGluRs
prevents neuronal death in embryonic chick spinal cell cultures treated with CSF
obtained from human ALS patients (Anneser et al., 2006).
Although ALS is an adult onset disease, recent studies utilising transgenic mouse
models of ALS (mutant SOD-1 transgenic mice) have revealed early pathological
alterations in the ALS affected spinal cord that occur long before the onset of clinical
symptoms (Durand et al., 2006; ElBasiouny et al., 2010). Data suggest
pre-symptomatic alterations in the intrinsic excitability of spinal motoneurons as early
as embryonic and neonatal stages. However, both hyperexcitability (Pieri et al., 2003;
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Kuo et al., 2004; Kuo et al., 2005; Zona et al., 2006; Pambo-Pambo et al., 2009;
Quinlan et al., 2011) and hypoexcitability (Bories et al., 2007; Pambo-Pambo et al.,
2009) of spinal motoneurons are reported in mutant SOD-1 mice. Neuronal
hyperexcitability is also reported in hypoglossal motoneurons in the brainstem of
mutant SOD-1 mice (van Zundert et al., 2008). In addition, there are likely to be
hyperexcitable alterations in pre-motor interneurons that mediate input to motoneurons
in the spinal cord and the brainstem of mutant SOD-1 mice (van Zundert et al., 2008;
Jiang et al., 2009). It may therefore be hypothesised that such early pre-symptomatic
hyperexcitability in pre-motor interneurons leads to a loss of excitatory synapses onto
motoneurons in both symptomatic mutant SOD-1 mice (Schutz, 2005; Avossa et al.,
2006) and human ALS patients (Nagao et al., 1998). Together, altered excitability of
motoneurons and interneurons, and possibly changes in synaptic inputs to motoneurons,
may therefore represent important pre-symptomatic features in the pathogenesis of ALS.
Given the limited understanding of the involvement of group I mGluRs in
glutamatergic excitotoxicity, and the incomplete understanding of early
pre-symptomatic alterations in neuronal excitability in the ALS affected spinal cord, the
present study aims to investigate the modulatory effects of group I mGluR activation in
spinal locomotor networks of neonatal mutant SOD-1 transgenic mice. In the previous
chapters, it has been shown that the activation of group I mGluRs modulates spinal
locomotor networks (Chapter 2) and possibly provides homeostatic control for
excitatory glutamatergic transmission upon spinal motoneurons (Chapter 3). Therefore,
this final chapter assesses whether the modulatory effects of group I mGluR activation
are altered in favour of neuroprotection or excitotoxicity in early pre-symptomatic
stages of spinal locomotor networks of neonatal mutant SOD-1 mice.
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Methods
Transgenic ALS model mice
Animals used included genetically engineered ALS model mice,
B6.Cg-Tg(SOD1*G93A)1Gur/J mice (mutant SOD-1 transgenic mice; The Jackson
Laboratory, Maine, USA) and their wild type C57/BL6 littermates. Mutant SOD-1
mice express high copy numbers of the mutant human superoxide dismutase-1 gene that
contains a substitution of Gly to Ala at amino acid 93 (G93A). The genotype of these
animals was determined before any experimental procedures were performed. Small
tissue samples were taken from tail tips. DNA was extracted and polymerase chain
reaction (PCR) was performed using the REDExtract-N-Amp Tissue PCR Kit
(Sigma-Aldrich) per the manufacturer’s instructions. The primers used were:
SOD1 forward primer 5’-CAT CAG CCC TAA TCC ATC TGA-3’
SOD1 reverse primer 5’-CGC GAC TAA CAA TCA AAG TGA-3’
Internal control forward primer 5’-CTA GGC CAC AGA ATT GAA AGA TCT-3’
Internal control reverse primer 5’-GTA GGT GGA AAT TCT AGC ATC ATC C-3’
Thermal cycling was performed on a PCR machine (PCR sprint thermal cycler, Thermo
Fisher Scientific, Massachusetts, USA) running the following programme:
1 95oC 3 min
2 95oC 30 sec
3 60oC 30 sec
4 72oC 45 sec (repeat steps 2-4 for 35 cycles)
5 72oC 2 min
6 10oC hold
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PCR products were run on a 1.5% agarose gel alongside a 1kb DNA ladder for analysis.
In vitro whole spinal cord preparations
In vitro whole spinal cord preparations were obtained from neonatal mice (P2 – P5)
by performing the same dissection techniques as described in the previous chapters.
The recording equipment was also arranged in the same way as described in the
previous chapters. Locomotor-related burst activity was induced pharmacologically
(NMDA 5 M, 5-HT 10 M and dopamine 50 M), and recorded with glass suction
electrodes attached to L1 or L2 ventral roots.
Spinal cord slice preparations
The spinal cord was dissected from neonatal mice (P4 – P8) as described in the
previous chapters. However, dissection and slicing of the isolated spinal cord were
performed in ice cold solution (dissecting solution, equilibrated with 95% O2 - 5% CO2,
~ 0˚C) that was designed to help minimise traumatic damage to neurons (Miles et al.,
2007). The isolated spinal cord was sliced 300 m thick, using a Vibratome (VT1200,
Leica Microsystems, Germany). Spinal cord slice preparations were then transferred
to oxygenated standard aCSF (equilibrated with 95% O2 - 5% CO2, room temperature),
to allow neurons to recover from traumatic damage.
Whole-cell patch-clamp recordings
The whole-call patch-clamp recording configuration used was as described in the
previous chapter (Chapter 3). Recorded neurons were limited to interneurons found in
the ventral half of the slice preparation. Large neurons (approximately 20 – 30 M in
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somal diameter) found in the most ventrolateral corners of the slice preparation were
avoided since they are likely to be spinal motoneurons.
Data analysis
Data from ventral root recordings were analysed offline using Dataview software
(courtesy of W. J. Heitler, University of St Andrews) as described in Chapter 2.
Whole-cell patch-clamp recordings were analysed using either Clampfit software
(Molecular Devices) or Dataview software. Data are reported as mean ± S.E.
Differences in means between data obtained from wild type and mutant SOD-1
interneurons or control and drug conditions were compared using Student’s t-tests.
Values of p < 0.05 were considered significant.
Solution and drugs
The dissecting aCSF solution contained 25 mM NaCl, 1.9 mM KCl, 1.2 mM
NaH2PO4, 10 mM MgSO4, 1 mM CaCl2, 26 mM NaHCO3, 1.5 mM kynurenic acid, 25
mM D-glucose and 188 mM sucrose (equilibriated with 95% O2 / 5% CO2).
The standard aCSF solution used for recording contained 127 mM NaCl, 3 mM KCl,
1.3 mM NaH2PO4, 1 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, and 10 mM D-glucose
(equilibrated with 95% O2/5% CO2).
The standard patch-clamp pipette solution contained 140 mM potassium methane
sulfonate, 10 mM NaCl, 1 mM CaCl2, 10 mM HEPES, 1 mM EGTA, 3 mM Mg-ATP,
and 0.4 mM GTP-Na2 (pH 7.2 – 7.3, adjusted with KOH).
Pharmacological agents used included: NMDA (N-methyl-D-aspartic acid), 5-HT
(5-hydroxytryptamine hydrochloride), dopamine (3,4-dihydroxyphenethylamine
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hydrochloride), purchased from Sigma-Aldrich (St Louis, MO); DHPG
((S)-3,5-dihydroxyphenylglycine), purchased from Tocris Bioscience (Bristrol, UK).
- 102 -
Results
Effects of group I mGluR activation on in vitro spinal cord preparations of WT and
mutant SOD-1 mice
To help assess whether group I mGluRs play a role in glutamatergic excitotoxicity
and the early pathogenesis of ALS, it was investigated whether the modulatory effects
of group I mGluR activation in spinal locomotor networks, demonstrated in Chapter 2,
are perturbed in locomotor networks of in vitro spinal cord preparations obtained from
neonatal mutant SOD-1 mice. The group I mGluR agonist DHPG (5 M) was bath
applied to pharmacologically activated rhythmic in vitro spinal cord preparations. In
both wild type and mutant SOD-1 in vitro spinal cord preparations, the application of
DHPG led to a significant decrease in the amplitude of locomotor-related ventral root
bursts (WT 13.0 ± 3.2 % reduction, n = 12, p = 0.001; Fig. 15Ai & Aii: SOD-1 12.1 ±
5.0 % reduction, n = 11, p = 0.014; Fig. 15Ai & 15Aiii). The degree and time course
of the DHPG-induced reduction in locomotor burst amplitude were very similar
between wild type and mutant SOD-1 preparations (Fig. 15A). Also DHPG
application caused a significant increase in the frequency of locomotor bursts both in
wild type and mutant SOD-1 preparations (WT 40.6 ± 11.7 % increase, n = 12, p =
0.006; Fig. 15Bi & 15Bii: SOD-1 32.2 ± 10.0 % increase, n = 11, p = 0.007; Fig. 15Bi
& 15Biii). Although the degree to which locomotor burst frequency increased was
similar between wild type and mutant SOD-1 preparations (Fig. 15B), the time course
of the increase in burst frequency differed, with the peak effect of DHPG application
reached ~10 minutes earlier in mutant SOD-1 preparations (Fig. 15Bi). These results
suggest that the modulatory effects of group I mGluR activation, at the level of spinal
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motoneurons that determine the intensity of final locomotor output, are not altered in
ALS affected in vitro spinal cord preparations. However, at the level of spinal
interneurons that generate the rhythm of locomotor network output, group I mGluR
activation may result in slightly different effects in wild type and ALS affected in vitro
spinal cord preparations of neonatal mice.
Intrinsic properties of WT and SOD-1 interneurons
Although the effects of group I mGluR activation on locomotor-related motoneuron
output recorded from pharmacologically activated in vitro spinal cord preparations of
wild type and mutant SOD-1 mice did not appear to differ, there did appear to be a
slight difference in the effects of group I mGluR activation on spinal interneurons
within locomotor CPG networks. There are two possible hypotheses that could
explain the slight difference in interneuron activity between the two preparations: 1)
intrinsic properties of interneurons that make up locomotor CPG networks are
fundamentally different between wild type and mutant SOD-1 transgenic spinal cords,
or 2) the responsiveness to group I mGluR activation is different between wild type and
mutant SOD-1 interneuron populations.
To assess the first hypothesis, that there are early alterations in the basic intrinsic
properties of interneurons in the spinal cord of mutant neonatal SOD-1 mice, whole-cell
patch-clamp recordings were performed from single interneurons found in the ventral
half of wild type and mutant SOD-1 spinal cord slice preparations (Fig. 16A). Starting
with the examination of sub-threshold interneuron properties, resting membrane
potentials of wild type and mutant SOD-1 interneurons were similar at values around
-60 mV (WT -62.2 ± 1.1 mV, n = 17; SOD -61.8 ± 1.1 mV, n = 17; Fig. 16B).
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Figure 15: Effects of group I mGluR activation in mutant SOD-1 in vitro spinal
cord preparations.
Ai) Time course plots showing a significant decrease in locomotor burst amplitude in
response to DHPG (5 M) application in wild type and mutant SOD-1 in vitro spinal
cord preparations. Aii) Pooled data, averaged for 5 min worth of recording in each
experimental condition, show a DHPG-induced significant decrease in locomotor burst
amplitude in wild type spinal cord preparations (n = 12). Aiii) Pooled data again
showing a DHPG-induced significant decrease in locomotor burst amplitude in mutant
SOD-1 spinal cord preparations (n = 11). Bi) Time course plots showing a significant
increase in locomotor burst frequency in response to DHPG application in wild type and
mutant SOD-1 in vitro spinal cord preparations. Arrows indicate peak effects of
increased burst frequency (while = SOD; black = WT). Bii) Pooled data showing a
DHPG-induced significant increase in locomotor burst frequency in wild type spinal
cord preparations. Biii) Pooled data again showing a DHPG-induced significant
increase in locomotor burst frequency in mutant SOD-1 spinal cord preparations. *
significantly different from control.
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Membrane resistance, calculated from I-V relationships generated from small voltage
steps (-70 to -50 mV, 2.5 mV increments, 150 ms) applied in voltage-clamp mode, was
also not significantly different between wild type (1.1 ± 0.2 G, n = 22) and mutant
SOD-1 (0.9 ± 0.2 G, n = 24) interneurons (Fig. 16C). Membrane capacitance, taken
as an indication of the cell size, again showed no significant differences between wild
type (13.4 ± 1.0 pF, n = 22) and mutant SOD-1 (15.1 ± 1.8 pF, n = 24) interneurons (Fig.
16D).
To examine the repetitive firing properties of wild type and mutant SOD-1
interneuron populations, steady state f-I relationships were obtained from current-clamp
protocols delivering steps of current pulses (1 sec; Fig. 17Ai). The f-I relationships
obtained from individual interneurons were then averaged in each population (WT 20
cells, SOD-1 23 cells; Fig. 17Aii). No apparent differences in the average f-I
relationships were observed (Fig. 17Aii), with the maximum firing frequencies
unchanged in wild type (23.2 ± 2.5 Hz, n = 20) and mutant SOD-1 (23.3 ± 1.4 Hz, n =
23) interneurons (Fig. 17Aiii). Although there were no significant differences in the
overall input-output relationships of interneurons in wild type and mutant SOD-1 spinal
cord slice preparations, to ensure that smaller changes in interneuron firing were not
missed, the properties of single action potentials were compared between wild type and
mutant SOD-1 interneuron populations. Single action potentials were evoked by brief
small square current pulses in current clamp mode (10 ms; Fig. 17Bi). Measurements
of the height and maximum rate of rise of individual action potentials demonstrated no
significant differences across wild type (height 89.7 ± 1.7 mV, max rise 94.1 ± 7.1
mV/ms, n = 23) and mutant SOD-1 (height 85.3 ± 2.2 mV, max rise 98.0 ± 7.9 mV/ms,
n = 24) interneurons (Fig. 17Bi, 17Bii & 17Biii). For measurements of the amplitude
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Figure 16: Sub-threshold properties of wild type and mutant SOD-1 interneu-
rons.  
A) Schematic showing a spinal cord slice preparation (courtesy of G. B. Miles, 
University of St Andrews).  B) Pooled data showing no significant difference in 
resting membrane potentials of wild type (n = 17) and mutant SOD-1 (n = 17) 
interneurons.  C) No significant difference in membrane resistance of wild type (n 
= 22) and mutant SOD-1 (n = 24) interneurons.  D) No significant difference in 
membrane capacitance of wild type (n = 22) and mutant SOD-1 (n = 24) interneu-
rons.  
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Figure 17: Intrinsic firing properties of wild type and mutant SOD-1 interneurons.
Ai) Repetitive firing evoked by brief (1 s) square current pulses in wild type and mutant
SOD-1 interneurons. Aii) Firing frequency vs. injected current (f-I) relationships
averaged across wild type (n = 20) and mutant SOD-1 (n = 23) interneuron populations.
Aiii) Maximum firing frequency was not significantly different between wild type and
mutant SOD-1 interneurons. Bi) Single action potentials elicited by brief square
current pulses (10 ms) in wild type and mutant SOD-1 interneurons. Bii) The height
and Biii) maximum rate of rise of action potentials and Biv) amplitude of the
after-hyperpolarisation (AHP) were all not significantly different between wild type (n =
23) and mutant SOD-1 (n = 24) interneurons. Ci) and Cii) The voltage threshold for
action potential generation, measured by injecting a ramp of current, was not
significantly different between wild type (n = 17) and mutant SOD-1 (n = 21)
interneurons.
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of the action potential after-hyperpolarisation (AHP), baseline membrane potentials
were kept near -60 mV by delivering appropriate bias currents. AHP amplitude was
again similar between wild type (5.2 ± 0.7 mV, n = 23) and mutant SOD-1 (4.9 ± 0.5
mV, n = 24) interneurons (Fig. 17Bi & 17Biv). The voltage threshold for action
potential generation was also assessed from current-clamp protocols applying slow
current ramps (3.3 to 83.3 pA/s; Fig. 17Ci). These measurements again demonstrated
no significant differences between wild type (-37.2 ± 2.4 mV, n = 17) and mutant
SOD-1 (-41.6 ± 1.7 mV, n = 21) interneuron populations (Fig. 17Cii).
A number of previous studies have suggested that an alteration in the properties of
Na+ currents is likely to be involved in early (embryonic and neonatal) pre-symptomatic
changes in neuronal excitability in mutant SOD-1 mice (Kuo et al., 2005; Zona et al.,
2006; van Zundert et al., 2008; Pambo-Pambo et al., 2009; Quinlan et al., 2011).
Given these findings, the present study analysed fast inactivating Na+ currents, elicited
by small voltage steps (-70 to +20 mV, 2.5 mV increments, 10 ms duration; Fig. 18Ai &
18Aii) from a holding potential at -60 mV. The analyses revealed no significant
differences in the peak density of these Na+ currents in wild type (-275.7 ± 21.6 pA/pF;
n = 22) and mutant SOD-1 (-305.1 ± 24.5 pA/pF; n = 25) interneurons (Fig. 18Aii &
18iii). However, an intriguing finding was that the voltage at which the peak Na+
current density was achieved was 7.5 mV apart in wild type (-20 mV) and mutant
SOD-1 (-27.5 mV) interneuron populations (Fig. 18Aii). Thus, there seems to be a
difference in the voltage dependence of fast inactivating Na+ currents in these two
interneuron populations. In comparison, both the density and voltage dependence of
K+ currents evoked by the delivery of long voltage pulses (-60 to 40 mV, 10 mV
increments, 150 ms duration; Fig. 18Bi & 18Bii) from a holding potential of -60 mV
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was not significantly different between the two interneuron populations (Fig. 18Bii).
The maximum density of K+ currents measured was 509.7 ± 40.7 pA/pF in wild type
interneurons (n = 22) and -553.6 ± 64.8 pA/pF in mutant SOD-1 interneurons (n = 24;
Fig. 18Bii & 18Biii).
Taken together, the present data indicate no significant differences in the vast
majority of intrinsic sub- and supra-threshold properties of interneurons recorded from
spinal cord slice preparations obtained from wild type and mutant SOD-1 mice.
However, in keeping with previous reports of alterations in the properties of Na+
currents in motoneurons of mutant SOD-1 mice, the voltage-dependence of activation
of fast inactivating Na+ currents appeared to be altered in spinal interneurons of mutant
SOD-1 mice.
Effects of group I mGluR activation in WT and mutant SOD-1 interneurons
Given the limited differences in intrinsic cellular properties of spinal interneurons
recorded from wild type and mutant SOD-1 in vitro spinal cord slice preparations, the
second hypothesis that these two interneuron populations differentially respond to the
activation of group I mGluRs was assessed next. DHPG (10 M) was bath applied to
spinal cord slice preparations obtained from wild type and mutant SOD-1 mice, while
whole-cell patch-clamp recordings were performed from ventral interneurons. Starting
with the examination of sub-threshold effects, DHPG application caused a small but
significant depolarisation of resting membrane potentials in both wild type (1.9 ± 0.8
mV depolarisation, n = 17, p = 0.036) and mutant SOD-1 (2.2 ± 0.7 mV depolarisation,
n = 17, p = 0.005) interneuron populations (Fig. 19Ai, 19Aii & 19Aiii), although the
degree of depolarisation was not different between the two populations (Fig. 19Ai,
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Figure 18: Voltage-clamp analyses of Na+ and K+ currents in wild type and mutant
SOD-1 interneurons.
Ai) Fast inactivating Na+ currents elicited by brief (10 ms) depolarising voltage steps in
wild type and mutant SOD-1 interneurons held at -60 mV. Aii) Plots of
current-voltage (I-V) relationships show different peak activation voltages of wild type
(black arrow, n = 22) and mutant SOD-1 (white arrow, n = 25) interneurons. Aiii)
Pooled data showing the density of peak Na+ currents was not significantly different
between wild type and mutant SOD-1 interneurons. Bi) K+ currents elicited by long
depolarising voltage steps (150 ms, up to +40 mV) in wild type and mutant SOD-1
interneurons held at -60 mV. Bii) Plots of I-V relationships and Biii) pooled data show
the voltage-dependence and density of peak K+ currents was not significantly different
between wild type and mutant SOD-1 interneurons.
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19Aii & 19Aiii). The DHPG-induced membrane depolarisation was not accompanied
by changes in input resistance (Fig. 19B) as calculated from I-V relationships obtained
from voltage-clamp protocols delivering small voltage steps (-70 to -50 mV, 2.5 mV
increments, 150 ms duration) from a holding potential at -60 mV.
Since it was demonstrated that the activation of group I mGluRs caused a net
reduction in the excitability of spinal motoneurons (Chapter 3), the modulatory effects
of group I mGluR activation upon firing properties of spinal interneurons were next
analysed. Steady state f-I relationships were generated from current-clamp protocols
applying steps of supra-threshold square current (1 s). The f-I relationships obtained
from individual interneurons were then averaged across wild type (n = 12) and mutant
SOD-1 (n = 12) interneuron populations. DHPG application did not shift the f-I
relationships in these two populations (Fig. 20Ai & 20Aii). The unchanged
excitability of spinal interneurons in response to DHPG application was statistically
confirmed by the result that the maximum firing frequencies were unaffected by DHPG
application in both wild type and mutant SOD-1 interneuron populations (Fig. 20Aiii).
These data are in contrast with the effects observed in spinal motoneurons reported in
the previous chapter (Chapter 3).
Although significant changes were not detected in the steady state f-I relationships of
spinal interneurons in response to group I mGluR activation, it was still possible that
small alterations in the parameters of individual action potentials might be uncovered.
To assess this possibility, single action potentials were evoked by brief pulses of
supra-threshold square current (10 ms; Fig. 20Bi) and the shape of single action
potentials were analysed. Similar to the group I mGluR-mediated modulatory effects
on motoneuron action potentials reported in the previous chapter (Chapter 3), the height
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Figure 19: Sub-threshold effects of group I mGluR activation in wild type 
and mutant SOD-1 interneurons.  
Ai) and Aii) Resting membrane potentials depolarised in response to DHPG appli-
cation (10 µM) in wild type and mutant SOD-1 interneurons.  Aiii) Pooled data 
show DHPG-induced significant membrane depolarisation to similar magnitude in 
wild type (n = 17) and mutant SOD-1 (n = 17) interneurons.  B) Pooled data show 
no significant effect on membrane resistance in response to DHPG application in 
wild type (n = 15) and mutant SOD-1 (n = 16) interneurons.  * = significantly 
different from control.
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Figure 20: Effects of group I mGluR activation on the firing properties of wild type
and mutant SOD-1 interneurons.
Ai) f-I relationships averaged across wild type interneurons (n = 12) in control condition
and the presence of DHPG (10 M). Aii) f-I relationships averaged across mutant
SOD-1 interneurons (n = 12) in control condition and the presence of DHPG. Aiii)
Pooled data show no significant effect on maximum firing frequency in response to
DHPG application in wild type and mutant SOD-1 interneurons. Bi) Single action
potentials elicited by brief square current pulses (10 ms) in control condition and the
presence of DHPG in wild type and mutant SOD-1 interneurons. Bii) The height of
action potentials was significantly reduced by DHPG application in both wild type (n =
15) and mutant SOD-1 (n = 16) interneuron populations. Biii) Maximum rate of rise
of action potentials was also significantly reduced by DHPG application in both wild
type and mutant SOD-1 interneuron populations. Biv) The amplitude of the AHP was
not affected by DHPG application in either interneuron population. Ci) The voltage
threshold for action potential generation was measured in wild type and mutant SOD-1
interneurons by injecting a ramp of current in control condition and the presence of
DHPG. Cii) Pooled data show that action potential threshold was significantly
hyperpolarised by DHPG application in wild type (n =11) but not in mutant SOD-1 (n =
12) interneurons. * = significantly different from control.
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and maximum rate of rise of single action potentials were significantly reduced by
DHPG application in both wild type (height 4.9 ± 1.6 mV reduction, n = 15, p = 0.007;
max rate 15.1 ± 3.5 % reduction, n = 15, p = 0.001) and mutant SOD-1 (height 4.8 ± 1.8
mV reduction, n = 16, p = 0.017; max rate 14.5 ± 4.7 % reduction, n = 16, p = 0.010)
interneurons (Fig. 20Bi, 20Bii & 20Biii). The degree to which DHPG application
reduced the height and maximum rate of rise of single action potentials was not
different between the two interneuron populations. For measurements of the amplitude
of the AHP, the baseline membrane potentials were set around -60 mV by applying
appropriate bias currents. The amplitude of the AHP was unchanged in response to
DHPG application in both wild type and mutant SOD-1 interneurons (Fig. 20Bi &
20Biv). The voltage threshold for action potential generation was also analysed using
current-clamp protocols involving slow ramps of current injection (3.3 to 83.3 pA/s; Fig.
20Ci). Interestingly, DHPG application led to differential effects on the voltage
threshold for action potential generation in wild type and mutant SOD-1 interneurons.
The action potential threshold was slightly but significantly hyperpolarised in response
to DHPG application in wild type interneurons (2.2 ± 1.0 mV hyperpolarisation, n = 11,
p = 0.044; Fig. 20Ci & 20Cii) whereas in mutant SOD-1 interneurons DHPG
application had no effect on the threshold for action potential generation (n = 12; Fig.
20Ci & 20Cii).
Next, it was assessed whether the group I mGluR-mediated effects on the shape of
individual action potentials in spinal interneurons were mediated via the modulation of
fast inactivating Na+ currents as reported in spinal motoneurons (Chapter 3). Fast
inactivating Na+ currents were elicited by brief voltage steps (-70 to +20 mV, 2.5 mV
increments, 10 ms duration; Fig. 21Ai & 21Aii) from a holding potential at -60 mV.
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Consistent with the group I mGluR-mediated reductions in the height and maximum
rate of rise of single action potentials in spinal interneurons, the density of fast
inactivating Na+ currents was reduced by DHPG application in both wild type and
mutant SOD-1 interneurons (Fig. 21Ai, 21Aii & 21Aiii). The peak Na+ current density
was significantly reduced in wild type (10.3 ± 2.3 % reduction, n = 15, p = 0.001) and
mutant SOD-1 (8.4 ± 3.4 % reduction, n = 16, p = 0.016) interneurons (Fig. 21Aiii),
although the degree of the reduction in peak Na+ current density was similar between
the two interneuron populations. In addition, analyses of K+ currents, elicited by long
voltage steps (-60 to +40 mV, 10 mV increments, 150 ms duration; Fig. 21Bi & 21ii)
from a holding potential at -60 mV, revealed no significant changes in the density and
voltage dependence of K+ currents in response to the application of DHPG in wild type
(n = 15) or mutant SOD-1 (n = 16) interneuron populations (Fig. 21Bi, 21Bii & 21Biii).
In summary, the activation of group I mGluRs in spinal interneurons showed some of
the same modulatory effects that were reported in spinal motoneurons (Chapter 3).
However, unlike in spinal motoneurons, the overall input-output relationships of spinal
interneurons, assessed by steady state f-I relationships, were unchanged by the
activation of group I mGluRs. However, as reported in spinal motoneurons (Chapter
3), group I mGluR-mediated reductions in the height and maximum rate of rise of single
action potentials were observed in spinal interneurons. Furthermore, the present data
indicate that these reductions in action potential parameters are likely to be related to a
reduction in the density of fast inactivating Na+ currents in spinal interneurons. The
modulatory effects of group I mGluR activation were, for the most part, similar between
wild type and mutant SOD-1 interneuron populations. The only difference between
the two populations was that a group I mGluR-mediated hyperpolarisation of the
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Figure 21: Effects of group I mGluR activation on Na+ and K+ currents in wild
type and mutant SOD-1 interneurons.
Ai) Plots of I-V relationships for fast inactivating Na+ currents in response to DHPG
application (10 M) in wild type interneurons (n = 15). Aii) Plots of I-V relationships
for fast inactivating Na+ currents in response to DHPG application in mutant SOD-1
interneurons (n = 16). Aiii) Pooled data show DHPG-mediated significant reduction in
the peak density of fast inactivating Na+ currents in both wild type and mutant SOD-1
interneurons. Bi) Plots of I-V relationships for K+ currents in response to DHPG
application in wild type interneurons (n = 15). Aii) Plots of I-V relationships for K+
currents in response to DHPG application in mutant SOD-1 interneurons (n = 16).
Aiii) Pooled data show no significant change in the peak density of K+ currents in both
wild type and mutant SOD-1 interneuron populations. * = significantly different from
control.
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voltage threshold for action potential generation was statistically confirmed in wild type
but not in mutant SOD-1 interneurons.
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Discussion
This final chapter has assessed the possible involvement of group I mGluRs in early
pre-symptomatic alterations in the excitability of spinal interneurons that make up
locomotor networks in the spinal cord of ALS model mice. Extracellular recordings
from lumbar ventral roots of pharmacologically activated in vitro whole spinal cord
preparations obtained from wild type and mutant SOD-1 neonatal mice demonstrated
that the activation of group I mGluRs resulted in a reduction in the amplitude of
locomotor-related burst activity and an increase in locomotor burst frequency in both
types of in vitro spinal cord preparations. Interestingly, the present results represent
the first report of rhythmic locomotor burst activity induced pharmacologically in
isolated spinal cord preparations obtained from mutant SOD-1 mice. A previous study
reported that rhythmic locomotor burst activity could not be induced from lumbar
locomotor networks of in vitro mutant SOD-1 spinal cord preparations obtained from
neonatal mice and concluded that the pathology of ALS involved disruption to neural
networks in the developing lumbar spinal cord (Amendola et al., 2004). The present
data do not seem to support this conclusion. However, it is difficult to directly
compare the results of the present study and those of Amendola et al. (2004) since the
latter study utilised a different strain of mutant SOD-1 (G85R) mice and did not include
dopamine for pharmacological activation of lumbar locomotor networks (Amendola et
al., 2004).
In the present study, the activation of group I mGluRs reduced the amplitude of
rhythmic locomotor burst activity to a similar extent in wild type and mutant SOD-1 in
vitro spinal cord preparations. The time course of this effect was also comparable
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between the two preparations. Therefore, there is little evidence that group I mGluR
activation exerts differential modulatory actions at the level of spinal motoneurons that
determine the intensity of the final locomotor output produced from wild type and
mutant SOD-1 spinal networks. In addition, the activation of group I mGluRs
increased rhythmic locomotor burst frequency to a similar extent in wild type and
mutant SOD-1 in vitro spinal cord preparations. However, an intriguing finding was
that the time course of this effect on burst frequency differed between wild type and
mutant SOD-1 preparations. The maximal effects of group I mGluR activation on
locomotor burst frequency were reached approximately 10 minutes earlier in mutant
SOD-1 spinal cord preparations. These data can be explained by two hypotheses: 1)
spinal interneurons that make up locomotor CPG networks have different intrinsic
neural properties in wild type and mutant SOD-1 mouse spinal cords, as suggested by
Amendola et al. (2004); or 2) the responsiveness of these spinal interneurons to the
activation of group I mGluRs is different between the two spinal cord preparations. To
assess these two hypotheses, whole-cell patch-clamp recordings from individual spinal
interneurons were performed in spinal cord slice preparations obtained from neonatal
wild type and mutant SOD-1 transgenic mice.
Because interneurons were selected from the entire ventral half of spinal cord slice
preparations, it is highly likely that whole-call patch-clamp recordings were made from
mixed groups of spinal interneurons that make up locomotor networks in mice. It
would be more ideal to limit the groups of spinal interneurons targeted for recordings
through the use of combined transgenic and developmental tools that identify specific
populations of CPG interneurons (Jessell, 2000; Goulding, 2009). However, the
present data reported in this chapter still represent one of the few studies into the basic
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intrinsic properties of interneurons in the ALS affected mammalian spinal cord or
brainstem (van Zundert et al., 2008). Although small alterations occurring in specific
interneuronal populations may not have been detected due to the heterogeneity of the
interneurons recorded, it was hoped in these recordings that global alterations in the
basic properties of ventral interneurons or alternatively changes in the proportions of
mixed neural groups might be uncovered in the spinal cord of mutant SOD-1 mice.
Unfortunately in the present study, few major differences were discovered between the
basic intrinsic properties of interneurons in wild type and mutant SOD spinal cord slice
preparations. However, a subtle difference in the voltage-dependence of activation of
fast inactivating Na+ currents was uncovered between the two interneuron populations.
The hyperpolarised peak activation voltage of fast inactivating Na+ currents in mutant
SOD-1 interneurons may represent a common, widespread perturbation in the
excitability of interneurons at a very early pre-symptomatic stage of the ALS affected
spinal cord in mice. However, further investigation is needed to prove this. For
example, more detailed measurements of the voltage-dependence of Na+ currents in
wild type and mutant SOD-1 spinal interneurons should be performed using modified
external and internal solutions designed to minimise voltage and space-clamp errors by
to reducing the amplitude of Na+ currents and isolating Na+ currents from other currents
such as K+ and Ca2+ currents (Chapter 3).
In previous studies, analyses of altered neuronal properties at early pre-symptomatic
stages of ALS affected spinal cord has concentrated on analyses of motoneurons in
mutant SOD-1 mouse spinal cord preparations. There are some data supporting
hypoexcitability of mutant SOD-1 motoneurons as indicated by, for example, a
reduction in the gain of steady state f-I relationships (Bories et al., 2007; Pambo-Pambo
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et al., 2009). However, hyperexcitability of mutant SOD-1 motoneurons has been
reported most frequently as an increase in the gain of steady state f-I relationships (Pieri
et al., 2003; Kuo et al., 2004; Kuo et al., 2005; Zona et al., 2006; van Zundert et al.,
2008; Pambo-Pambo et al., 2009; Quinlan et al., 2011). The hyperexcitability of
mutant SOD-1 motoneurons is likely mediated by modulation of Na+ currents with
effects including an increase in persistent Na+ currents (Kuo et al., 2005; van Zundert et
al., 2008; Quinlan et al., 2011), an altered balance between persistent Na+ and Ca2+
inward currents (Pambo-Pambo et al., 2009) or the faster recovery of Na+ channels from
fast inactivation (Zona et al., 2006). Given these previous studies of Na+
current-mediated hyperexcitability of mutant SOD-1 motoneurons and the present study
demonstrating the hyperpolarised peak activation voltage of fast inactivating Na+
currents in mutant SOD-1 interneurons, it seems that functional alterations in Na+
channels are highly likely to be involved in the neuronal hyperexcitability observed at
early pre-symptomatic stages in ALS.
In the present chapter, it was also investigated whether interneurons of wild type and
mutant SOD-1 spinal cord slice preparations respond differentially to the activation of
group I mGluRs. Previous studies demonstrate that group I mGluRs play a
neuroprotective role in kainate-induced excitotoxicity in adult rat spinal cord slice
preparations (Pizzi et al., 2000; Valerio et al., 2002) and both neuroprotective and
neurotoxic roles in neuronal death in embryonic chick spinal cord cultures treated with
CSF obtained from human ALS patients (Anneser et al., 2006). In the previous
chapter (Chapter 3), it was demonstrated that the activation of group I mGluRs
contributes to the homeostatic control of motoneuron excitability and glutamatergic
excitatory inputs to spinal motoneurons. In the present chapter, the activation of group
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I mGluRs resulted in similar, but fewer, modulatory effects on the intrinsic properties of
interneurons in both wild type and mutant SOD-1 spinal cord slice preparations. A
significant depolarisation of resting membrane potentials was observed in spinal
interneurons following the activation of group I mGluRs, but the degree of membrane
depolarisation was smaller in both wild type and mutant SOD-1 interneurons than that
observed in spinal motoneurons (Chapter 3). The steady state f-I relationships were
not altered by group I mGluR activation in both wild type and mutant SOD-1
interneuron populations, unlike the modulatory effect demonstrated in spinal
motoneurons. These results indicate that the activation of group I mGluRs does not
affect the generation of repetitive action potential firing in spinal interneurons.
However, analyses of single action potentials revealed that in both wild type and mutant
SOD-1 interneurons the height and maximum rate of rise of action potentials were
significantly reduced by the activation of group I mGluRs. Voltage-clamp analyses of
fast inactivating Na+ currents suggested that the group I mGluR-mediated reductions in
action potential parameters may relate to a reduction in the peak density of fast
inactivating Na+ currents in spinal interneurons, as was reported in motoneurons
(Chapter 3).
There was only one differential effect of group I mGluR activation in wild type and
mutant SOD-1 interneuron populations. The activation of group I mGluRs
hyperpolarised the voltage threshold for action potential generation in wild type but not
in mutant SOD-1 interneurons. In the previous chapter (Chapter 3) the group I
mGluR-mediated hyperpolarisation of voltage thresholds for action potential generation
was shown to be mediated via mGluR5 activation in spinal motoneurons. Hence it
may be hypothesised that signalling pathways that involve mGluR5 activation are
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altered in interneurons of the mutant SOD-1 mouse spinal cord. It is known that
subtypes of group I mGluRs are differentially expressed in motor nuclei of the spinal
cord and the brainstem, such that more mGluR1 expression is detected in motor nuclei
vulnerable to ALS neurodegeneration, while more mGluR5 expression is detected in
motor nuclei that are resistant to ALS neurodegeneration (Laslo et al., 2001; Anneser et
al., 2004; Ma et al., 2006). Comparisons of the effects of group I mGluRs in ALS
vulnerable and resistant motor nuclei may therefore advance our understanding of the
potential neuroprotective or neurotoxic subtype specific roles of group I mGluRs in
ALS.
Although it is very hard to relate results obtained from mixed types of spinal
interneurons that make up locomotor CPG networks with group I mGluR-mediated
modulatory effects observed in rhythmically active in vitro whole spinal cord
preparations, there are some findings worth discussing in this final chapter. A
hyperpolarisation of voltage thresholds for action potential generation in response to
group I mGluR activation in wild type interneurons might be a possible candidate that
underlies the group I mGluR-mediated increase in locomotor burst frequency recorded
from in vitro whole spinal cord preparations. However, this seems unlikely to be the
case, because a hyperpolarisation of action potential thresholds was not observed in
mutant SOD-1 interneurons, yet the group I mGluR-mediated increase in locomotor
burst frequency had a quicker time course effect in mutant SOD-1 compared to wild
type in vitro spinal cord preparations. The faster time course of the effect on burst
frequency in mutant SOD-1 whole spinal cord preparations may reflect increased
excitability of mutant SOD-1 interneurons as evidenced by a hyperpolarised activation
voltage for fast inactivating Na+ currents. However more detailed analyses will be
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required to confirm this. In addition, the group I mGluR-mediated depolarisation of
resting membrane potentials in wild type and mutant SOD-1 interneurons may be most
likely to contribute to the increase in locomotor burst frequency recorded from both
types of in vitro whole spinal cord preparations.
The present chapter represents the first study of the intrinsic neural properties of
ventral interneurons and the modulatory effects of group I mGluR activation upon
interneurons in the spinal cord of ALS affected neonatal mice. Given recent studies
that have started to focus on the involvement of pre-motor interneurons and synaptic
inputs to motoneurons in neurodegenerative diseases (Nagao et al., 1998; Schutz, 2005;
Avossa et al., 2006; Stephens et al., 2006), it will become of increasing importance to
understand the physiological characteristics of different types of interneurons that make
up motor networks as well as to uncover alterations that may occur to their neuronal
properties due to pathological processes in the mammalian spinal cord.
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Concluding remarks
The present study has demonstrated the role of group I mGluRs for intrinsic
neuromodulation in locomotor networks of the mammalian spinal cord. Modulatory
effects of group I mGluR activation have been assessed in locomotor networks, not only
of the healthy mouse spinal cord, but also of the mouse spinal cord affected by the
neurodegenerative disease, amyotrophic lateral sclerosis (ALS).
Activation of group I mGluRs in pharmacologically activated (NMDA, 5-HT, and
dopamine) in vitro whole spinal cord preparations obtained from healthy wild type
neonatal mice resulted in a decrease in the amplitude of locomotor-related rhythmic
burst activity recorded from lumbar ventral roots. Concurrently, the activation of
group I mGluRs in these in vitro spinal cord preparations increased the frequency of
rhythmic locomotor burst activity. These results together suggest that the activation of
group I mGluRs indeed modulates on-going locomotor network activity produced by
both motoneurons and interneurons that make up central pattern generator (CPG) for
locomotion in the mammalian spinal cord. The group I mGluR-mediated decrease in
locomotor burst amplitude and the increase in locomotor burst frequency were also
evident in whole in vitro spinal cord preparations obtained from ALS affected neonatal
mice.
Whole-cell path-clamp recordings from motoneurons and interneurons within spinal
locomotor networks have revealed a wide range of cellular mechanisms that may
explain group I mGluR-mediated modulatory effects upon on-going locomotor network
activity observed in the mouse spinal cord. In motoneurons, despite limited excitatory
effects, such as membrane depolarisation, the net group I mGluR-mediated action was a
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reduction in excitability, most likely reflecting a reduction in fast inactivating Na+
currents. In addition to modulating the intrinsic properties of motoneurons, group I
mGluRs were also found to modulate synaptic inputs received by motoneurons,
specifically reducing locomotor-related excitatory drive to motoneurons via both pre-
and post-synaptic modulatory mechanisms. These data together indicate that both
reduced excitability of motoneurons and a decrease in synaptic drive to motoneurons are
likely to underlie group I mGluR-mediated reductions in locomotor burst amplitude
observed in the whole spinal networks.
Recordings from spinal interneurons of the ventral horn provided evidence that
membrane depolarisation in response to group I mGluR activation is likely to contribute
to the increase in locomotor burst frequency recorded from in vitro whole spinal cord
preparations. Given the heterogeneous nature of the interneurons recorded from, it
will be important for future studies to investigate the potential specificity of group I
mGluR-mediated effects on different neural populations within CPG networks. Such
analyses of group I mGluR-mediated effects on specific populations of neurons will
become easier as more distinct interneuron populations are defined using genetic
techniques based on increasing knowledge of spinal cord development.
In both motoneurons and interneurons, group I mGluR activation led to excitatory
effects, such as membrane depolarisation and hyperpolarisation of action potential
thresholds, as well as inhibitory effects, such as a decrease in Na+ current density and a
reduction in excitatory synaptic transmission from pre-motor interneurons to spinal
motoneurons. The range of opposing actions of group I mGluRs reported in the
present study suggests that group I mGluRs may act as important ‘homeostatic
neuromodulators’ within locomotor networks of the mammalian spinal cord, perhaps
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stabilising the state of the network to ensure output is produced within an appropriate
range (Harris-Warrick and Johnson, 2010).
In the present study no major alterations were discovered in the actions of group I
mGluRs on locomotor networks of ALS affected neonatal mice. However, this does
not preclude involvement of these receptors in later stages of the disease. An
intriguing finding was that interneurons recorded from spinal cord slice preparations
obtained from ALS affected mice had hyperpolarised activation voltages for fast
inactivating Na+ currents compared to wild type interneurons. This finding is
particularly interesting in the context of previous studies which have shown alterations
in Na+ channel function in motoneurons of ALS model mice at very early
developmental stages (Kuo et al., 2005; Zona et al., 2006; van Zundert et al., 2008;
Quinlan et al., 2011). Although it remains to be determined whether altered
motoneuron, and perhaps interneuron, excitability due to perturbations in Na+ channel
function is critically involved in the pathology of ALS, this is an area in which further
work should be conducted. It is intriguing that the only approved treatment for ALS,
the drug riluzole, acts not only on glutamate release but also persistent Na+ channels
(Bellingham, 2011).
In summary, the present study has provided a number of novel results that
demonstrate the important neuromodulatory role of group I mGluRs at the level of
whole spinal locomotor networks as well as single neurons, motoneurons and
interneurons, within the mammalian spinal cord in health and disease. As well as
advancing our basic understanding of spinal motor control, the present work highlights
the potential importance of studying neuromodulatory systems in neurodegenerative
diseases. It is hoped that a greater knowledge of neuromodulation, including that
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mediated by group I mGluRs, will ultimately lead to the development of useful clinical
strategies for the treatment of neurodegenerative diseases such as ALS.
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